<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">32586</article-id><article-id pub-id-type="doi">10.7554/eLife.32586</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Crk proteins transduce FGF signaling to promote lens fiber cell elongation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-99432"><name><surname>Collins</surname><given-names>Tamica N</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-99433"><name><surname>Mao</surname><given-names>Yingyu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99434"><name><surname>Li</surname><given-names>Hongge</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">§</xref></contrib><contrib contrib-type="author" id="author-104858"><name><surname>Bouaziz</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99435"><name><surname>Hong</surname><given-names>Angela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17594"><name><surname>Feng</surname><given-names>Gen-Sheng</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99436"><name><surname>Wang</surname><given-names>Fen</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99437"><name><surname>Quilliam</surname><given-names>Lawrence A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99438"><name><surname>Chen</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99439"><name><surname>Park</surname><given-names>Taeju</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99440"><name><surname>Curran</surname><given-names>Tom</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-54495"><name><surname>Zhang</surname><given-names>Xin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5555-0825</contrib-id><email>xz2369@columbia.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Departments of Ophthalmology, Pathology and Cell Biology</institution><institution>Columbia University</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Pathology</institution><institution>University of California San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Center for Cancer Biology and Nutrition</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution><institution>Indiana University School of Medicine</institution><addr-line><named-content content-type="city">Indianapolis</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Rehabilitation Medicine</institution><institution>Third Military Medical University</institution><addr-line><named-content content-type="city">Chongqing</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">The Children's Research Institute</institution><institution>Children's Mercy Kansas City</institution><addr-line><named-content content-type="city">Kansas City</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-6760"><name><surname>Horsley</surname><given-names>Valerie</given-names></name><role>Reviewing Editor</role><aff id="aff7"><institution>Yale University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, United States</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, United States</p></fn><fn id="fn1"><p><sup>§</sup>Current address: Department of Molecular Genetics &amp; Cell Biology, University of Chicago, Chicago, IL 60637</p></fn><fn id="fn2"><p><sup>¶</sup>Current address: Department of Microbiology &amp; Immunology, Indiana University School of Medicine, Indianapolis, IN 46202</p></fn><fn id="fn3"><p>The authors declare that there is no conflict of interest with regard to the manuscript.</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>23</day><month>01</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e32586</elocation-id><history><date date-type="received" iso-8601-date="2017-10-07"><day>07</day><month>10</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2018-01-23"><day>23</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Collins et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Collins et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-32586-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.32586.001</object-id><p>Specific cell shapes are fundamental to the organization and function of multicellular organisms. Fibroblast Growth Factor (FGF) signaling induces the elongation of lens fiber cells during vertebrate lens development. Nonetheless, exactly how this extracellular FGF signal is transmitted to the cytoskeletal network has previously not been determined. Here, we show that the Crk family of adaptor proteins, Crk and Crkl, are required for mouse lens morphogenesis but not differentiation. Genetic ablation and epistasis experiments demonstrated that <italic>Crk</italic> and <italic>Crkl</italic> play overlapping roles downstream of FGF signaling in order to regulate lens fiber cell elongation. Upon FGF stimulation, Crk proteins were found to interact with Frs2, Shp2 and Grb2. The loss of Crk proteins was partially compensated for by the activation of Ras and Rac signaling. These results reveal that Crk proteins are important partners of the Frs2/Shp2/Grb2 complex in mediating FGF signaling, specifically promoting cell shape changes.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.32586.002</object-id><title>eLife digest</title><p>As an embryo develops, its cells divide multiple times to transform into the specialized cell types that form our tissues and organs. To carry out specific roles, cells need to be of a certain shape. For example, in mammals, the cells that make up the main portion of the eye lens, develop into a fiber-like shape to be perfectly aligned with each other. This enables them to transmit light to the retina at the rear end of the eye. To do so, the lens cells increase over 1000 times in length with the help of a group of proteins called the Fibroblast Growth Factor, or FGF for short.</p><p>The FGF pathway includes a network of interacting proteins that transmit signals to molecules inside the lens cells to control how they specialize and grow. However, until now it was not clear how it does this. Here, Zhang et al. used mouse lens-cells grown in the laboratory to investigate how FGF signaling causes cells to change their structure. The experiments revealed two related proteins called Crk and Crkl that linked the FGF pathway with another signaling system. When these two proteins were removed from the lens cells, the lens cells were still able to specialize, but could no longer grow in length. This suggests that these two processes are independent of each other.</p><p>Moreover, Crk and Crkl helped the cells to change shape by increasing the amount of another group of proteins called Ras, which are known to both help cells to specialize and to regulate their shape. Zhang et al. discovered that the amount of Ras proteins determined whether cells specialized or modified their shape by changing the organization of proteins in the cell.</p><p>Millions of children are born with cataracts, a disease caused when lens cells fail to shape properly. A better knowledge of FGF signaling may help to understand how cataracts develop and inspire future treatments. Moreover, the pathways identified in this study could also apply to other organs and diseases in which FGF signaling is active.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>FGF</kwd><kwd>Frs2</kwd><kwd>Shp2</kwd><kwd>Grb2</kwd><kwd>Ras</kwd><kwd>cell shape</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>EY017061</award-id><principal-award-recipient><name><surname>Collins</surname><given-names>Tamica N</given-names></name><name><surname>Mao</surname><given-names>Yingyu</given-names></name><name><surname>Li</surname><given-names>Hongge</given-names></name><name><surname>Hong</surname><given-names>Angela</given-names></name><name><surname>Zhang</surname><given-names>Xin</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>5P30EY019007</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xin</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001818</institution-id><institution>Research to Prevent Blindness</institution></institution-wrap></funding-source><award-id>Jules and Doris Stein professorship</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Crk proteins are critical mediators of FGF signaling to control cell shape changes.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>During the development of complex multicellular organisms, changes in epithelial cell morphology are essential for the tissue-specific cell differentiation patterning that leads to the subsequent formation of functional organs (<xref ref-type="bibr" rid="bib64">Settleman and Baum, 2008</xref>). This is particularly clear when considering the formation of the ocular lens, which has served as a model system to delineate many developmental pathways (<xref ref-type="bibr" rid="bib15">Cvekl and Zhang, 2017</xref>; <xref ref-type="bibr" rid="bib22">Gunhaga, 2011</xref>). The development of the mouse lens begins at embryonic day 9.5 when the optic vesicle extends toward the presumptive lens ectoderm, inducing the latter to thicken into a cuboidal layer of epithelial cells commonly referred to as the lens placode. At E10.5, the cells making up the lens placode undergo apical constriction to form the lens pit, which eventually closes at its anterior surface to form the lens vesicle (<xref ref-type="bibr" rid="bib14">Chauhan et al., 2011</xref>). After the newly differentiated primary fiber cells extend anteriorly from the posterior region of the lens vesicle, the anterior epithelial cells begin to migrate posteriorly towards the equatorial region of the lens, at which point they begin to differentiate into secondary fiber cells that continue to occupy the space within the lens interior. This process is accompanied by up to a 1000-fold increase in the length of the newly formed secondary fiber cells, which coordinate with the primary fiber cells to organize an elegant concave pattern that maintains the structural integrity and transparency of the mature lens (<xref ref-type="bibr" rid="bib6">Bassnett, 2005</xref>; <xref ref-type="bibr" rid="bib41">McAvoy et al., 1999</xref>; <xref ref-type="bibr" rid="bib67">Sue Menko, 2002</xref>).</p><p>Previously proposed models that have been considered for the mechanism by which lens fiber cells elongate consist of microtubule reorganization, increased cell volume and actin dynamics (<xref ref-type="bibr" rid="bib5">Audette et al., 2017</xref>). Microtubules are prominent components of the cytoskeleton lining the plasma membrane of lens fiber cells. They are oriented longitudinally along the lens with their minus end towards the anterior pole and their plus ends facing the posterior (<xref ref-type="bibr" rid="bib10">Byers and Porter, 1964</xref>). which is consistent with the presence of microtubule organizing centers at the apical ends of lens fiber cells (<xref ref-type="bibr" rid="bib35">Lo et al., 2003</xref>). However, Beebe et al reported that Nocodazole inhibition of microtubule polymerization failed to disrupt fiber cell elongation in chick lens explants (<xref ref-type="bibr" rid="bib7">Beebe et al., 1979</xref>). Instead, they proposed that the expansion of cell volume was the key mechanism by which fiber cells elongated to form the functional mature lens. However, utilizing precise measurement techniques, it was later found that there was no apparent increase in lens volume in vivo at the onset of fiber cell elongation (<xref ref-type="bibr" rid="bib6">Bassnett, 2005</xref>). The differentiation of lens epithelial cells into lens fiber cells is also associated with the assembly of actin filaments beneath the cortical membrane (<xref ref-type="bibr" rid="bib73">Weber and Menko, 2006</xref>). When this cortical actin structure was inhibited by cytochalasin D in lens explants, both the differentiation and elongation of lens cells were blocked. Nevertheless, neither the disruption of the cell adhesion molecules N-cadherin or β1-integrin nor the ablation of the actin regulators Rac1 and Rho completely prevented the lengthening of lens fiber cells (<xref ref-type="bibr" rid="bib36">Logan et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Maddala et al., 2011</xref>, <xref ref-type="bibr" rid="bib40">2015</xref>; <xref ref-type="bibr" rid="bib51">Pathania et al., 2016</xref>; <xref ref-type="bibr" rid="bib53">Pontoriero et al., 2009</xref>). Consequently, how the actin cytoskeleton is controlled during fiber cell elongation has remained an open question.</p><p>Fibroblast Growth Factor (FGF) signaling is known to play an important role in lens cell differentiation and elongation. Transgenic expression of human FGF-1 using an αA-crystallin promoter was found to induce lens epithelial cells to acquire elongated shapes and fiber cell characteristics (<xref ref-type="bibr" rid="bib60">Robinson et al., 1995</xref>). In explant cultures, FGF was also found to promote lens fiber cell differentiation and elongation in a dose dependent manner (<xref ref-type="bibr" rid="bib37">Lovicu and McAvoy, 2001</xref>; <xref ref-type="bibr" rid="bib42">McAvoy and Chamberlain, 1989</xref>). Conversely, genetic ablation of FGF receptors leads to a complete loss of lens cell differentiation and elongation (<xref ref-type="bibr" rid="bib78">Zhao et al., 2008</xref>). Several proteins have been implicated in the direct engagement with these active FGF receptors, including Frs2/3, Grb14, Shb, PLCγ and Crk (<xref ref-type="bibr" rid="bib9">Brewer et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Klint and Claesson-Welsh, 1999</xref>). Of particular interests are Crk and the related protein Crkl, which are mammalian homologs of the viral <italic>Crk</italic> oncogene that prossess the ability to promote the tyrosine phosphorylation of cellular proteins (<xref ref-type="bibr" rid="bib17">Feller, 2001</xref>). Lacking intrinsic tyrosine kinase activity, the Crk family of proteins act as adaptors that transduce signals from upstream phosphotyrosine-containing proteins to downstream SH3-interacting partners (<xref ref-type="bibr" rid="bib8">Birge et al., 2009</xref>). Biochemical studies have shown that FGF2-stimulated endothelial cell proliferation is dependent on the binding of Crk to the phosphorylated tyrosine residue 463 in FGFR1 (<xref ref-type="bibr" rid="bib32">Larsson et al., 1999</xref>). In line with this finding, <italic>Crk</italic> null mice display some of the cardiovascular and cranial features of Noonan syndrome, which is caused by aberrant Ras-MAPK signaling (<xref ref-type="bibr" rid="bib49">Park et al., 2006</xref>; <xref ref-type="bibr" rid="bib57">Roberts et al., 2007</xref>; <xref ref-type="bibr" rid="bib61">Schubbert et al., 2006</xref>; <xref ref-type="bibr" rid="bib69">Tartaglia et al., 2001</xref>; <xref ref-type="bibr" rid="bib70">Tartaglia et al., 2007</xref>). Crkl was also identified as a component of an FGF8-induced feed forward loop, resulting in anchorage-independent cell growth (<xref ref-type="bibr" rid="bib63">Seo et al., 2009</xref>). Consistent with this, the human <italic>CRKL</italic> gene lies within the chromosome 22q11 deletion region that causes DiGeorge syndrome, which shares the pharyngeal and cardiac defects seen in <italic>Fgf8</italic>-deficient mice (<xref ref-type="bibr" rid="bib43">Moon et al., 2006</xref>). Despite these findings implicating Crk and Crkl in FGF signaling, a recent study has shown that mutating their putative Y463 binding site in Fgfr1 did not produce any observable phenotype in transgenic mice (<xref ref-type="bibr" rid="bib9">Brewer et al., 2015</xref>). Therefore, the potential role and mechanism of Crk proteins in FGF signaling remain uncertain.</p><p>In this study, we showed that the lens specific knockout of <italic>Crk</italic> and <italic>Crkl</italic> disrupted lens fiber cell elongation without affecting differentiation, suggesting that lens cell morphogenesis can be uncoupled from differentiation during development. FGF loss- and gain-of-function experiments demonstrated that Crk proteins act downstream of FGF signaling to enhance ERK phosphorylation. Contrary to the previous belief that Crk proteins directly bind to the Fgfr, we found that mutating the purported Crk docking site on Fgfr1 failed to perturb lens development or Crk phosphorylation. Instead, our data showed that Crkl was recruited to the Frs2/Shp2/Grb2 complex after FGF stimulation. Crk/Crkl deficient animals phenocopied Rac1 but not Rap1 mutants, and activation of Rac1 and Ras signaling partially reversed the observed lens elongation defects caused by the deletion of Crk and Crkl. These results show that the Crk family of adaptor proteins are essential partners of the Frs2/Shp2/Grb2 complex that forms during FGF signaling, and are specifically required for stimulating the actin reorganization that is necessary for the morphological shaping of lens cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Ablation of Crk and Crkl caused lens defects</title><p>We observed that Crk and Crkl proteins displayed a restricted localization pattern in the lens. At E10.5, Crk and Crkl were predominantly confined to the apical side of the lens vesicle (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, arrows), away from the basal side where integrins interact with the basement membrane (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, dotted lines). By contrast, Crk and Crkl exhibited a more diffuse pattern at E12.5 when the posterior lens vesicle cells gave rise to the primary lens fibers (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). However, by E14.5, Crk and Crkl were specifically enriched in the transitional zone where the lens epithelial cells begin to differentiate and elongate into the secondary lens fiber cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, arrowheads). Using an antibody that recognizes the phosphorylated forms of both of these proteins, we were able to observe that the phosphorylation of Crk and Crkl also mainly occurs in the transition zone of the lens at this stage of development (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, arrowheads). These results suggest that Crk activity is under dynamic regulation as the lens cells undergo successive morphological changes during development.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.32586.003</object-id><label>Figure 1.</label><caption><title>Crk and Crkl are essential for lens development.</title><p>(<bold>A</bold>) Crk and Crkl immunostaining were localized to the invaginating lens vesicle at E10.5 (arrows) and to the elongating lens fiber cells near the transitional zone of the lens at E14.5 (arrowheads). These staining patterns were specifically lost in the CrkCKO lens. The dotted lines enclose the region of the lens and the disorganization of the retina was marked with asterisks (<bold>B</bold>) The phosphorylation of both Crk and Crkl was noticeably absent in the CrkCKO lens (arrowheads). (<bold>C</bold>) The CrkCKO lens size was significantly reduced with the anterior lens epithelium rotated sideways (arrows) and the disorganized lens fiber cells markedly shortened (double headed arrows).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.32586.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title><italic>Crk</italic> and <italic>Crkl</italic> single mutants did not display lens phenotype.</title><p>(<bold>A–C</bold>) H/E staining showed that the individual deletion of <italic>Crk</italic> and <italic>Crkl</italic> did not affect aspects of lens development.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig1-figsupp1-v2"/></fig></fig-group><p>We next ablated <italic>Crk</italic> genes using <italic>Pax6<sup>Le</sup>-Cre</italic>, also known as <italic>Le-Cre,</italic> which is initially active in the lens placode and later in the lens epithelium (<xref ref-type="bibr" rid="bib3">Ashery-Padan et al., 2000</xref>). As expected, this resulted in the loss of both Crk/Crkl and pCrk/pCrkl in the <italic>Pax6<sup>Le</sup>-Cre;Crk<sup>flox/flox</sup>;Crkl<sup>flox/flox</sup></italic> (CrkCKO) lens after E10.5 (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>, dotted line). Although deletion of either <italic>Crk</italic> or <italic>Crkl</italic> alone did not perturb lens development (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–C</xref>), the CrkCKO lens displayed a reduction in lens size, rotation of the lens epithelial layer, and disorganization of the lens fiber cells at E14.5 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, arrow). Using F-actin staining to better delineate individual cell shapes, we observed a significant reduction in the length of the lens fiber cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). In addition to these fully penetrant lens phenotypes, the neural retina was often observed to aberrantly protrude toward the diminished lens. This observation is consistent with the known role of the properly developed lens in the correct placement of the retina (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, asterisks) (<xref ref-type="bibr" rid="bib3">Ashery-Padan et al., 2000</xref>).</p><p>During lens development, the transcription factors Pax6 and Prox1 are of vital importance for the normal differentiation of the transparent lens. Pax6 controls lens induction and fate determination while Prox1 regulates fiber cell differentiation and crystallin expression (<xref ref-type="bibr" rid="bib3">Ashery-Padan et al., 2000</xref>; <xref ref-type="bibr" rid="bib4">Audette et al., 2016</xref>). Interestingly, notwithstanding the severe morphological defects including the frequent ventral rotation of the lens epithelial layer, Prox1, Pax6 and multiple forms of crystallin (α,β,γ) were still expressed (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). In addition, the polarity of the lens fiber cells was also preserved as evidenced by the localization of Zo-1 and β1 integrin to the apical and basal sides of the lens, respectively (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, arrowheads). However, there were both a reduction in cell proliferation and an increase in apoptosis in the lens epithelial cells as shown by Ki67 and TUNEL staining (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>, arrowheads), which likely accounted for the diminished lens epithelial layer (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, arrowheads). Collectively, these data show that Crk proteins are dispensable for lens differentiation and polarity, but are essential for proliferation, survival and elongation of the cells that make up the structurally mature lens.</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.32586.005</object-id><label>Figure 2.</label><caption><title>Molecular defects in the <italic>Crk</italic> and <italic>Crkl</italic> double mutant lens.</title><p>(<bold>A</bold>) There were no significant changes in the staining intensity of the lens determinant markers Prox1 and Pax6. (<bold>B</bold>) Further, none of the three forms of Crystallins (α, β, γ) displayed any changes in staining intensity in the CrkCKO lens. (<bold>C</bold>) The polarity of the CrkCKO lens fiber cells was maintained as indicated by both the apical expression of Zo-1 and the basal expression of β1 integrin. (<bold>D</bold>) The number of Ki67-expressing proliferative cells was significantly decreased and the number of TUNEL-positive apoptotic cells was increased (arrowheads). (<bold>E</bold>) Quantification of proliferation and apoptosis in wild type and CrkCKO lens. Student’s t test, *p&lt;0.01, **p&lt;0.001, <italic>n</italic> = 4.</p><p><supplementary-material id="fig2sdata1"><object-id pub-id-type="doi">10.7554/eLife.32586.006</object-id><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-32586-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig2-v2"/></fig></sec><sec id="s2-2"><title>Crk proteins act downstream of FGF signaling to control fiber cell elongation</title><p>To investigate the role of Crk proteins in FGF signaling, we took a three-prong approach, combining in vitro, in vivo and ex vivo experiments. First, we performed loss-of-function experiments to examine whether FGF signaling is required for Crk protein activity. Consistent with previous studies showing that FGF signaling is essential for early lens development (<xref ref-type="bibr" rid="bib18">Garcia et al., 2011</xref>), we observed that genetic ablation of Fgfr1/2 in <italic>Pax6<sup>Le</sup>-Cre;Fgfr1<sup>flox/flox</sup>;Fgfr2<sup>floxflox</sup></italic> (FgfrCKO) mutants disrupted lens vesicle invagination at E10.5 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Although the mutant lens cells still expressed Pax6, the lens specific marker αA-crystallin was not induced. Importantly, whereas the control embryos displayed the phosphorylation of Erk and Crk in the invaginating lens vesicle, these staining patterns were absent in FgfrCKO lens cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). To further corroborate these results in vitro, we isolated primary mouse embryonic fibroblast (MEF) cells from <italic>Fgfr1<sup>flox/flox</sup>;Fgfr2<sup>floxflox</sup></italic> embryos and infected them with a Cre-expressing adenovirus to ablate Fgfr1 and Fgfr2. Unlike wild type controls, these mutant MEF cells failed to elevate the level of pCrk/Crkl and pErk upon FGF stimulation, demonstrating that both Crk and Erk proteins are under the tight regulation of FGF signaling (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). To probe the relationship between Crk and Erk, we next infected <italic>Crk<sup>flox/flox</sup>;Crkl<sup>floxflox</sup></italic> MEF cells with the Cre adenovirus to deplete Crk proteins (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). As a result, both the intensity and duration of FGF-stimulated Erk phosphorylation were down regulated, suggesting that Crk proteins modify the quantity of FGF-ERK signaling by elevating and prolonging ERK activation. Consistent with this, we noticed that Erk phosphorylation was prominent in the elongating primary lens fiber cells at E12.5 and in the transitional zone of the lens at E14.5 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In the CrkCKO mutant lens, however, pERK staining was significantly reduced (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Together, this data shows that Crk proteins regulate FGF-induced Erk activation in the developing lens.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.32586.007</object-id><label>Figure 3.</label><caption><title>Crk proteins mediate FGF signaling in Erk phosphorylation.</title><p>(<bold>A</bold>) Genetic ablation of Fgfr1 and Fgfr2 disrupted the proper formation of the lens vesicle with the phosphorylation of Erk and Crk/Crkl proteins being noticeably absent. (<bold>B</bold>) Mouse Embryonic fibroblast (MEF) cells treated with FGF2 displayed an increase in pCrk/Crkl and pErk levels, which were abrogated by the removal of Fgfr1 and Fgfr2 using a Cre-expressing adenovirus. (<bold>C</bold>) Ablation of Crk proteins in MEF cells reduced FGF2-induced Erk phosphorylation. The pErk/Erk ratios were noted below the pERK blot. (<bold>D</bold>) The CrkCKO lens displayed a significant decrease in pERK staining compared to the wild type lens.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.32586.008</object-id><label>Figure 3—figure supplement 1.</label><caption><title>The Y463F mutation in <italic>Fgfr1</italic> (<italic>Fgfr1<sup>Crk</sup></italic>) did not affect the phosphorylation of Crk and Erk proteins that is essential for lens development.</title><p>(<bold>A</bold>) FGF2 was still able to induce an upregulation of pCrk/Crkl and pERK in <italic>Fgfr1<sup>Crk/Crk</sup>;Fgfr2<sup>flox/flox</sup></italic> MEF cells after treatment with a Cre-expressing adenovirus. (<bold>B</bold>) A homozygous <italic>Fgfr1<sup>Crk/Crk</sup></italic> mutation did not affect pCrk/Crkl staining (arrows) in the lens even after the genetic removal of other Fgf receptors (<italic>Fgfr2-4</italic>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig3-figsupp1-v2"/></fig></fig-group><p>The second approach we took to probe the role of <italic>Crk</italic> genes in FGF signaling was based on gain-of-function experiments. We utilized two <italic>Fgf3</italic> transgenes that are driven by the αA-crystallin promoter to target the lens (<xref ref-type="bibr" rid="bib59">Robinson et al., 1998</xref>), which led to an anterior expansion of pErk staining (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The <italic>Fgf3<sup>OVE393A</sup></italic> line displayed excessive elongation of the lens fiber cells that protruded through the corneal epithelium, while the <italic>Fgf3<sup>OVE391</sup></italic> line showed a more modest enlargement of the lens (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). After crossing these mice with <italic>Crk</italic> mutants, however, lens abnormalities in both lines were suppressed and ectopic phospho-Erk staining was abrogated. The length of the fiber cells was reduced to the same size as those seen in the CrkCKO mutants, demonstrating that <italic>Crk</italic> genes were necessary for the induction of fiber cell elongation by FGF (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). <italic>Fgf3</italic> overexpression also led to premature exiting of the cell cycle as indicated by the loss of the cell proliferation marker Ki67 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, arrowheads) and an increase in expression of the cell cycle inhibitor p57 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, arrows). As a result, the anterior lens epithelial cells differentiated prematurely to express the fiber cell markers Jag1 and C-Maf at the expense of the epithelial cell markers E-cadherin and Foxe3. Interestingly, the cell cycle and differentiation abnormalities were not rescued after crossing the <italic>Fgf3</italic> transgenic mice with CrkCKO mutants. These genetic epistasis experiments further highlighted that the specific functionality of <italic>Crk</italic> genes is in mediating FGF signaling for lens cell elongation but not differentiation.</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.32586.009</object-id><label>Figure 4.</label><caption><title>Crk/Crkl deletion prevented FGF-induced lens cell elongation without affecting differentiation.</title><p>(<bold>A</bold>) Overexpression of <italic>Fgf3</italic> in <italic>Fgf3<sup>OVE391</sup></italic> and <italic>Fgf3<sup>OVE393A</sup></italic> strains resulted in increased lens fiber cell elongation and overall lens sizes. However, both of these phenotypes were suppressed after being crossed with the CrkCKO mutant, indicating a genetic epistasis interaction between the FGF and Crk signaling pathways. (<bold>B</bold>) Quantification of lens fiber cell length. One-way ANOVA test followed by Tukey's multiple comparisons test, *p&lt;0.01, <italic>n</italic> = 3. (<bold>C</bold>) Deletion of the <italic>Crk</italic> genes did not prevent the premature differentiation phenotype observed in the <italic>Fgf3</italic> overexpressing lens, as indicated by a reduction of lens progenitor cell markers (Ki67, E-cad and Foxe3) and an increase of differentiation cell markers (p57, Jag1, and C-Maf) within the presumptive lens epithelial layer (arrows). Nonetheless, pERK staining was significantly reduced in the CrkCKO;<italic>Fgf3<sup>OVE391</sup></italic> lens. (<bold>D</bold>) The Cre-expressing adenovirus induces efficient genetic recombination in lens explant cultures as indicated by the <italic>ROSA<sup>mTmG</sup></italic> reporter. In <italic>Crk<sup>flox/flox</sup>;Crkl<sup>floxflox</sup></italic> explants, the Cre-mediated deletion of Crk proteins prevented Fgf2 from inducing cell shape changes.</p><p><supplementary-material id="fig4sdata1"><object-id pub-id-type="doi">10.7554/eLife.32586.010</object-id><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="fig" rid="fig7">Figure 7P</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-32586-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig4-v2"/></fig><p>In the third approach, we used the mouse lens explant system to test the direct role of Crk proteins in FGF-induced fiber cell elongation (<xref ref-type="bibr" rid="bib30">Korol et al., 2014</xref>). In this assay, the explant lens isolated from P3 mouse embryos carrying <italic>Crk<sup>flox/flox</sup>;Crkl<sup>floxflox</sup></italic> alleles was infected with a Cre-expressing adenovirus to achieve acute genetic ablation. This avoids any potential complication that may stem from defects in early lens development or other compartments of the eye. Using a <italic>ROSA<sup>mTmG</sup></italic> mouse line that switches the reporter expression from membrane TdTomato to membrane GFP upon Cre mediated recombination, we showed that a 2 day incubation period with the virus was sufficient to induce genetic changes in all lens epithelial cells (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). In control explants, β-catenin staining revealed a robust elongation of the lens epithelial cells after FGF2 exposure. By contrast, the lens epithelial cells in <italic>Crk<sup>flox/flox</sup>;Crkl<sup>floxflox</sup></italic> explants treated with the Cre adenovirus retained the epithelial specific hexagonal shape without any obvious signs of elongation. Taken together, these three lines of evidence established that Crk proteins are essential mediators of FGF signaling whose specific function relates to the fiber cell elongation that occurs during lens development.</p></sec><sec id="s2-3"><title>The Frs2 binding site on Fgfr1 is required for Crk signaling</title><p>Previous studies have suggested that Crk proteins bind directly to the phosphorylated tyrosine-463 residue on Fgfr1 to mediate downstream signaling (<xref ref-type="bibr" rid="bib32">Larsson et al., 1999</xref>). Surprisingly, mice carrying a Y463F mutation in <italic>Fgfr1</italic> (<italic>Fgfr1<sup>Crk</sup></italic>) lacked any observable phenotypes and were reported to be both viable and fertile (<xref ref-type="bibr" rid="bib9">Brewer et al., 2015</xref>). The lack of abnormality in <italic>Fgfr1<sup>CRK</sup></italic> mice prompted us to examine whether it was due to the compensatory functions of other Fgf receptors. We isolated MEF cells from <italic>Fgfr1<sup>Crk</sup>;Fgfr2<sup>flox</sup></italic> mice and removed <italic>Fgfr2</italic> by Cre-mediated recombination in vitro. Although we have shown above that genetic inactivation of Fgfr1 and Fgfr2 together was sufficient to abrogate FGF signaling in MEF cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), FGF was still able to induce phosphorylation of Crk/Crkl and Erk in <italic>Fgfr1<sup>CRK</sup></italic> MEF cells after the deletion of <italic>Fgfr2</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). We next investigated the requirement of the Y463 residue of Fgfr1 for Crk signaling in lens development. For this purpose, we genetically ablated all FGF receptors (<italic>Fgfr2</italic>, <italic>Fgfr3</italic> and <italic>Fgfr4</italic>) with the exception of <italic>Fgfr1</italic> in the mouse lens, resulting in only a modest reduction in lens size (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Even in such a stringent genetic background, a homozygous <italic>Fgfr1<sup>Crk</sup></italic> mutation did not further worsen the lens phenotype or disrupt pCrk staining. These results show that the putative Y463 Crk binding site on Fgfr1 is dispensable for FGF-dependent lens development and Crk signaling.</p><p>Since our biochemical and genetic data did not support a functional role for the direct interaction between FGF receptors and the Crk protein, we next explored whether FGF signaling may engage Crk indirectly through intermediaries. Frs2 is a myristylated protein located at the plasma membrane that binds to Fgf receptors specifically at a juxtamembrane site. With multiple tyrosine residues phosphorylated by activated Fgf receptors, Frs2 acts as a nexus of FGF signaling by presenting easily accessible docking sites for the phosphotyrosine-binding proteins Shp2 and Grb2, which in turn activate Ras-MAPK signaling. Taking advantage of a mutant <italic>Fgfr1</italic> allele (<italic>Fgfr1<sup>ΔFrs</sup></italic>) that lacks the Frs2 binding site (<xref ref-type="bibr" rid="bib26">Hoch and Soriano, 2006</xref>), we showed that formation of the lens vesicle was indeed disrupted in <italic>Pax6<sup>Le</sup>-Cre;Fgfr1<sup>flox/ΔFrs</sup>;Fgfr2<sup>flox/flox</sup></italic> embryos (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), which resembled the phenotype of FgfrCKO null mutants (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Importantly, we observed that the loss of the Fgfr-Frs2 interaction also abrogated the phosphorylation of Crk proteins. This was further confirmed in vitro using <italic>Fgfr1<sup>flox/ΔFrs</sup>;Fgfr2<sup>floxflox</sup></italic> MEF cells infected with a Cre adenovirus. The resulting <italic>Fgfr1<sup>-/ΔFrs</sup>;Fgfr2<sup>-/-</sup></italic> MEF cells failed to elevate the levels of pERK or pCrk/Crkl in response to FGF2 stimulation (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), demonstrating that the Frs2-binding site on Fgfr1 is necessary for Crk signaling.</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.32586.011</object-id><label>Figure 5.</label><caption><title>Crk proteins are recruited to the Frs2-Shp2-Grb2 complex in FGF signaling.</title><p>(<bold>A–B</bold>) Mutating the Frs2-bindng site in <italic>Fgfr1<sup>ΔFrs</sup></italic> resulted in the loss of pCrk/Crkl in the <italic>Pax6<sup>Le</sup>-Cre;Fgfr1<sup>flox/ΔFrs</sup>;Fgfr2<sup>floxflox</sup></italic> mutant lens. (<bold>B</bold>) FGF2 was unable to induce the phosphorylation of Crk proteins in <italic>Fgfr1<sup>flox/ΔFrs</sup>;Fgfr2<sup>floxflox</sup></italic> MEF cells after treatment with the Cre expressing adenovirus. (<bold>C</bold>) FGF2-induced pCrk/Crkl and pErk were significantly downregulated in both <italic>Frs2</italic> and <italic>Shp2</italic> null MEF cells. (<bold>D</bold>) Shp2 was successfully depleted in the Frs2CKO;Shp2CKO lens, which resulted in the loss of pCrk/Crkl staining. (<bold>E</bold>) pERK was downregulated in both CrkCKO and Shp2CKO lenses and was further reduced in CrkCKO;Shp2CKO mutants. (<bold>F</bold>) FGF2-induced pCrk/Crkl and pErk were down regulated in <italic>Grb2</italic> deficient MEF cells. (<bold>G</bold>) TAP-taged Crkl pulled down Frs2, Shp2 and Grb2 after FGF2 stimulation. Note that only the slower moving phosphorylated form of Frs2 successfully interacted with Crkl.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig5-v2"/></fig></sec><sec id="s2-4"><title>Crk proteins are recruited indirectly to FGF receptors by the Frs2-Shp2-Grb2 complex</title><p>The above results suggested that Frs2 may be the adaptor protein that recruits Crk to Fgf receptors. To test this idea, we first examined Crk phosphorylation in MEF cells that were mutated by the Cre-mediated deletion of <italic>Frs2</italic> and <italic>Shp2</italic>. As shown in <xref ref-type="fig" rid="fig5">Figure 5C</xref>, phosphorylation of Crk proteins induced by FGF was significantly reduced in <italic>Frs2</italic> null MEF cells. Moreover, in MEF cells lacking the Frs2 interacting protein Shp2, even the normally seen basal levels of pCrk were lost. We have previously showed that both Frs2 and its binding partner Shp2 have relatively slow turnover rates in vivo (<xref ref-type="bibr" rid="bib33">Li et al., 2014</xref>). As a result, the conditional inactivation of <italic>Frs2</italic> or <italic>Shp2</italic> alone exhibited only a modest lens phenotype. Combined deletion of <italic>Frs2</italic> and <italic>Shp2</italic> in <italic>Le-Cre;Frs2<sup>flox/floxs</sup>;Shp2<sup>floxflox</sup></italic> (Frs2CKO;Shp2CKO) embryos, however, did block lens development at E14.5. At this stage, the control lens displayed a significant accumulation of Shp2 protein in the transitional zone of the lens, which is also the area of maximum pErk and pCrk/Crkl staining (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, arrows). In contrast, neither Shp2 nor the pCrk/Crkl proteins were detectable in the Frs2CKO;Shp2CKO lens. Notably, an in vitro ablation of either Crk or Shp2 reduced the Erk phosphorylation that is normally induced by FGF (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig5">Figure 5D</xref>). Consistent with this, both CrkCKO and Shp2CKO embryos at E12.5 continued to display residual levels of pErk staining in the lens (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). In CrkCKO;Shp2CKO mutants, however, pErk staining was entirely abolished, suggesting that Shp2 and the Crk family of proteins act synergistically to regulate Erk signaling.</p><p>Grb2 is another binding partner of Frs2 that is essential for the activation of Ras-MAPK signaling. In Grb2-depleted MEF cells, we observed a similar reduction in Crk and Erk signaling in response to FGF stimulation (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). The attenuation of Crk phosphorylation in <italic>Frs2</italic>, <italic>Shp2</italic> and <italic>Grb2</italic> deficient cells raises the possibility that Crk proteins are recruited to the Fgf receptors via the Frs2-Shp2-Grb2 complex. To probe the physical interaction between these proteins, we transfected NIH-3T3 cells with a TAP-Crkl construct that encodes the Crkl protein conjugated to a tandem affinity purification (TAP) tag used for purification (<xref ref-type="bibr" rid="bib23">Hallock et al., 2015</xref>). When the concentration of FGF was increased, we observed a shift of Frs2 mobility in our immunoblot analysis that is representative of the phosphorylated form of Frs2 being generated as has been previously reported (<xref ref-type="fig" rid="fig5">Figure 5G</xref>) (<xref ref-type="bibr" rid="bib31">Kouhara et al., 1997</xref>). Consistent with this, there was also an increase in the levels of pErk present in the cell lysates. Interestingly, immunoprecipitated TAP-Crkl only pulled down the phosphorylated form of Frs2 induced by FGF stimulation, which was also accompanied by Shp2 and Grb2. Overall these results indicate that the Frs2-Shp2-Grb2 complex is responsible for recruiting Crk proteins to the activated Fgf receptor.</p></sec><sec id="s2-5"><title>Rac1 is a downstream effector of crk proteins in lens fiber cell elongation</title><p>Crk proteins have been implicated in the activation of the small molecular GTPases Rac1 and Rap1, which play important roles in cell adhesion, cytoskeletal rearrangement and cell shape changes (<xref ref-type="bibr" rid="bib8">Birge et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Feller, 2001</xref>). Previous studies have reported that the conditional deletion of Rac1 in the lens resulted in impaired actin polymerization that lead to a morphologically impaired lens (<xref ref-type="bibr" rid="bib39">Maddala et al., 2011</xref>). Since <italic>Rac2</italic> has also been reported to be expressed in the lens (<xref ref-type="bibr" rid="bib55">Rao et al., 2004</xref>), we decided to inactivate both <italic>Rac1</italic> and <italic>Rac2</italic> to compare their phonotype with that of the <italic>Crk</italic> mutants. Immunofluorescence confirmed the specific depletion of Rac1 in the <italic>Pax6<sup>Le</sup>-Cre;Rac1<sup>flox/flox</sup>;Rac2<sup>-/-</sup></italic> (RacCKO) lens (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). Unlike the CrkCKO lens, however, the RacCKO lens did not display a decrease in pErk staining (<xref ref-type="fig" rid="fig6">Figure 6C–D</xref>). Nonetheless, depletion of Rac proteins resulted in a lens fiber cell elongation defect, albeit milder than that seen in the CrkCKO lens (<xref ref-type="fig" rid="fig6">Figure 6E–G</xref>). To further explore the relationship between Rac and Crk proteins, we utilized the <italic>R26-Rac1<sup>LSL-G12V</sup></italic> allele that results in the expression of a constitutively active form of Rac1 (Rac1CA) after the Cre mediated excision of its STOP cassette (<xref ref-type="bibr" rid="bib65">Srinivasan et al., 2009</xref>). In the <italic>Pax6<sup>Le</sup>-Cre;Crk<sup>flox/flox</sup>;Crkl<sup>floxflox</sup>;R26-Rac1<sup>LSL-G12V</sup></italic> (CrkCKO;Rac1CA) lens, there was a statistically significant increase in fiber cell length as compared to that of the CrkCKO lens (<xref ref-type="fig" rid="fig6">Figure 6H and U</xref>). The partial rescue of the CrkCKO phenotype by Rac1 activation supports the idea that Rac1 is a downstream effector of Crk in the signaling pathways that lead to lens fiber cell elongation.</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.32586.012</object-id><label>Figure 6.</label><caption><title>Rac proteins are downstream effectors of Crk signaling.</title><p>(<bold>A–D</bold>) Staining of Rac-depleted lenses with a pErk antibody showed no significant difference in staining intensity. (<bold>E–H</bold>) Phalloidin (F-actin) staining revealed that the length of lens fiber cells (indicated by arrows) was significantly reduced in CrkCKO and RacCKO lenses, which was partially reversed after the activation of Rac signaling in CrkCKO;Rac1CA lenses. (<bold>I–N</bold>) The Rap1 depleted mutants displayed a detachment of the lens fiber cells from the anterior side of the lens epithelial cells (arrow) and Smooth Muscle Actin (SMA) staining within the lens epithelial layer itself (arrowheads). These phenotypes were absent both in the control and the Crk/Crkl depleted lenses. (<bold>O–T</bold>) Immunstaining of the Rac and Rap1 depleted lenses with progentior (Foxe3, E-cad, Ki67) and differentiation (C-Maf, Jag1,p57) markers did not reveal any defects in differentiation or any further shortening of the fiber cells. (<bold>I</bold>) Quantification of fiber cell lengths. One-way ANOVA test followed by Tukey's multiple comparisons test, *p&lt;0.01, <italic>n</italic> = 3.</p><p><supplementary-material id="fig6sdata1"><object-id pub-id-type="doi">10.7554/eLife.32586.013</object-id><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6U</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-32586-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig6-v2"/></fig><p>Rap1 is also known to be targeted by Crk proteins via activation of the guanine nucleotide exchange factor (GEF), C3G, and FGFR1 has previously been reported to activate Rap1 in endothelial cells (<xref ref-type="bibr" rid="bib54">Quilliam et al., 2002</xref>; <xref ref-type="bibr" rid="bib75">Yan et al., 2008</xref>). We reasoned that if Rap1 was a downstream effector of Crk proteins in FGF signaling, <italic>Rap1</italic> and <italic>Crk</italic> deficient lenses should phenocopy each other as well. In agreement with a previous report (<xref ref-type="bibr" rid="bib40">Maddala et al., 2015</xref>), we found that the conditional knockout of two <italic>Rap1</italic> genes (<italic>Pax6<sup>Le</sup>-Cre;Rap1a<sup>flox/flox</sup>;Rap1b<sup>flox/flox</sup></italic> (Rap1CKO)) disrupted the epithelial polarity of the lens, leading to an ectopic expression of the epithelial-mesenchymal-transition (EMT) marker smooth muscle actin (SMA) in lens epithelium cells (<xref ref-type="fig" rid="fig6">Figure 6I–L</xref>). Due to cell adhesion defects, the posterior lens fiber cells also failed to remain attached to the anterior epithelial cells as is represented by a noticeable gap in the anterior part of the lens. In contrast, neither of these phenotypes were observed in the CrkCKO mutant lens (<xref ref-type="fig" rid="fig6">Figure 6M and N</xref>), which instead displayed a more severe lens fiber cell elongation defect than the Rap1CKO mutants. We also considered the possibility that <italic>Rap1</italic> and <italic>Rac</italic> may be functionally redundant in the developing ocular lens. The combined deletion of these four genes in <italic>Le-Cre;Rac1<sup>flox/flox</sup>;Rac2<sup>-/-</sup>;Rap1a<sup>flox/flox</sup>;Rap1b<sup>flox/flox</sup></italic> (RacCKO;Rap1CKO) embryos, however, did not produce any lens differentiation abnormalities or enhance the fiber cell elongation defects previously observed in the RacCKO mutants (<xref ref-type="fig" rid="fig6">Figure 6O–U</xref>). Taken together, these results argue against the Rap1 family of proteins being downstream targets of Crk signaling during lens development.</p></sec><sec id="s2-6"><title>Activation of ras signaling ameliorated lens fiber cell elongation defects present in the <italic>Crk</italic> mutant</title><p>The above experiments showed that a constitutively active form of Rac1 resulted in only modest attenuation of the lens fiber cell elongation defects seen in the CrkCKO mutant, suggesting that there exist additional downstream effectors of the Crk proteins that are important in regulating fiber cell shape. As we have observed a significant downregulation of pErk in the CrkCKO mutant lens, one potential candidate is the Ras-MAPK signaling pathway. We subsequently crossed the CrkCKO mutant with a <italic>Kras<sup>LSL-G12D</sup></italic> mouse, which harbors a Cre-inducible allele of the oncogenic G12D mutated <italic>Kras</italic> (<xref ref-type="bibr" rid="bib71">Tuveson et al., 2004</xref>). Because this mutant is expressed from the endogenous <italic>Kras</italic> locus, it is expected to activate Ras signaling at a normal physiological level as opposed to being overexpressed. Consistent with this, we observed a modest increase in pERK staining in the <italic>Pax6<sup>Le</sup>-Cre</italic>;<italic>Crk<sup>flox/flox</sup>;Crkl<sup>flox/flox</sup>;Kras<sup>LSL-G12D</sup></italic> (CrkCKO;<italic>Kras<sup>G12D</sup></italic>) lens (<xref ref-type="fig" rid="fig7">Figure 7A–C</xref>). Although TUNEL staining showed that the cell apoptosis defect was not rescued in the CrkCKO; <italic>Kras<sup>G12D</sup></italic> lens, the number of proliferative Ki67 positive cells increased significantly, which can likely explain the extension of the lens epithelium as evidenced by E-cadherin staining (<xref ref-type="fig" rid="fig7">Figure 7D–L</xref>). Importantly, the length of the lens fiber cells in the CrkCKO;<italic>Kras<sup>G12D</sup></italic> lens increased to about 90% of that of the control lens, demonstrating that the activation of Ras signaling can largely rescue the fiber elongation defects caused by the loss of Crk proteins (<xref ref-type="fig" rid="fig7">Figure 7M–P</xref>). This result provides strong genetic evidence that Ras signaling plays an essential role in Crk-mediated lens cell shape changes.</p><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.32586.014</object-id><label>Figure 7.</label><caption><title>Constitutive Kras signaling can compensate for the loss of Crk and Crkl in lens development.</title><p>(<bold>A–C</bold>) Despite the loss of Crk and Crkl, Erk phosphorylation was partially recovered in CrkCKO;<italic>Kras<sup>G12D</sup></italic> lenses. (<bold>D–F</bold>) A signficant amount of TUNEL positive cells remained in both CrkCKO and CrkCKO;<italic>Kras<sup>G12D</sup></italic> lenses. (<bold>G–L</bold>) Cell proliferation indicated by Ki57 increased in the CrkCKO;<italic>Kras<sup>G12D</sup></italic> lens as compared to the CrkCKO lens, but there was no significant difference in staining intensity for the differentiation markers E-cad and Jag1. (<bold>M–P</bold>) Lens fiber cell length increased significantly in CrkCKO;<italic>Kras<sup>G12D</sup></italic> lenses as compared to CrkCKO ones. Fiber cell length was measured based on F-actin staining and statistical analysis was performed using the one-way ANOVA test followed by Tukey's multiple comparisons test (*p&lt;0.01, <italic>n</italic> = 3). (<bold>Q</bold>) Model of Crk function in FGF signaling. The binding of FGF to its receptor induces the assembly of the Frs2-Shp2-Grb2 complex, which subsequently activates Ras signaling to promote lens differentiation. When FGF signaling is further elevated at the transitional zone of the lens, Crk proteins were additionally recruited by the Frs2-Shp2-Grb2 complex to further promote Ras and Rac signaling, resulting in actin cytoskeletal rearrangement and cell shape changes.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32586-fig7-v2"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The ocular lens is derived from a single cell type that undergoes an orderly set of successive differentiation change that are represented by various cell shape alterations occurring along the developmental timeline. This makes it an excellent model for studying the cell signaling pathways involved in these morphological processes. Although FGF signaling is known to regulate both lens fiber cell differentiation and elongation, it is unclear whether these two functions can be separated at the mechanistic level. In this study, we successfully showed that the Crk family of adaptor proteins specifically mediate FGF signaling in the control of lens cell shape but not differentiation. Contrary to previous claims, we demonstrated that the putative Crk binding site on Fgfr1 is dispensable. Rather, the recruitment of Crk proteins to the Frs2-Shp2-Grb2 complex via the Frs2 docking site on Fgf receptors was observed. Our study further showed that the downstream Crk effectors involved in regulating the precise cytoarchitecture of the lens are primarily Ras and to a lesser extent Rac1, but not Rap1 (<xref ref-type="fig" rid="fig7">Figure 7Q</xref>). These results identify Crk proteins as the essential adapters that link FGF signaling to cytoskeletal dynamics.</p><p>This study also demonstrated that Crk and Crkl play essential overlapping functions in embryonic lens development. Whereas lack of either Crk or Crkl did not disrupt lens development in the mouse embryos, combined deletion of Crk and Crkl led to a profound defect in lens fiber cell elongation. There is a substantial overlap between Crk and Crkl in many biological functions including the Reelin pathway (<xref ref-type="bibr" rid="bib50">Park and Curran, 2008</xref>), neuromuscular synapse formation (<xref ref-type="bibr" rid="bib24">Hallock et al., 2010</xref>), migration of T cells to sites of inflammation (<xref ref-type="bibr" rid="bib27">Huang et al., 2015</xref>) and podocyte morphogenesis (<xref ref-type="bibr" rid="bib19">George et al., 2014</xref>). These studies and ours confirm that single and double floxed mice for Crk and Crkl are crucial models for investigating the distinct and overlapping biological functions of these closely related proteins.</p><p>Crk and Crkl are versatile adaptor proteins that can interact with a wide spectrum of signaling molecules (<xref ref-type="bibr" rid="bib8">Birge et al., 2009</xref>). Previous studies have shown that they can be recruited by molecular scaffolds such as Dab1 to transmit Reelin signaling or p130Cas and paxillin to participate in integrin signaling (<xref ref-type="bibr" rid="bib45">Nojima et al., 1996</xref>; <xref ref-type="bibr" rid="bib52">Petit et al., 2000</xref>; <xref ref-type="bibr" rid="bib62">Sekine et al., 2012</xref>). Following growth factor stimulation, Crk and Crkl are also known to bind directly to several receptor tyrosine kinases (RTKs) via their SH2 domains and become rapidly phosphorylated at their specifically targeted tyrosine residues (Y221 in Crk and Y207 in Crkl) (<xref ref-type="bibr" rid="bib2">Antoku and Mayer, 2009</xref>; <xref ref-type="bibr" rid="bib16">Feller et al., 1994</xref>). Upon ligand stimulation, FGF receptors undergo autophosphorylation at multiple tyrosine residues, which serve as docking sites for downstream signaling proteins. Previous studies have suggested that Crk and Crkl can recognize a conserved phosphotyrosine residue in FGFRs (pY463 in FGFR1 and pY466 in FGFR2) through their SH2 domains (<xref ref-type="bibr" rid="bib32">Larsson et al., 1999</xref>). By examining the Y463F mutant of Fgfr1 both in vitro and in vivo, we showed that this site was dispensable for FGF signaling with regards to the activation of Crk proteins. By contrast, we showed that Crk proteins interact with Frs2 and Shp2 proteins, and that their loss prevents FGF-induced Crk phosphorylation. This is reminiscent of Frs2’s function in response to nerve growth factor (NGF) to assemble a complex containing Crk, C3G, Rap1 and Braf in order to prolong MAPK signaling (<xref ref-type="bibr" rid="bib28">Kao et al., 2001</xref>). Interestingly, in that case, the binding of Crk requires the Shp2-docking site on Frs2. We have also identified Grb2 as yet another interacting partner of Crkl and showed that Grb2 was required for FGF-induced phosphorylation of Crk and Crkl. Since both Frs2 and Shp2 interact with Grb2, we would like to suggest that the assembly of the entire Frs2-Shp2-Grb2 complex is necessary for the recruitment of the Crk family of adaptor proteins to Fgf receptors.</p><p>C3G, Sos and Dock1 were the first three GEFs identified to be directly associated with the SH3 domains of Crk (<xref ref-type="bibr" rid="bib25">Hasegawa et al., 1996</xref>; <xref ref-type="bibr" rid="bib46">Oda et al., 1994</xref>; <xref ref-type="bibr" rid="bib68">Tanaka et al., 1994</xref>). While Sos is primarily involved in the activation of Ras-MAPK signaling, C3G and Dock1 promote the exchange of GDP for GTP in the small GTPases Rap1 and Rac1 (<xref ref-type="bibr" rid="bib8">Birge et al., 2009</xref>). These active GTP-bound proteins subsequently regulate integrin signaling and actin polymerization (<xref ref-type="bibr" rid="bib20">Gloerich and Bos, 2011</xref>; <xref ref-type="bibr" rid="bib56">Ridley, 2011</xref>). We showed that the <italic>Crk</italic> knockout did not recapitulate the <italic>Rap1</italic> mutant lens phenotype, ruling out Rap1 as a critical downstream effector of Crk proteins. Instead, activation of Rac1 and, more importantly, Ras effectively rescued the lens fiber elongation defect seen in <italic>Crk</italic> mutants. In addition to these results further clarifying the downstream targets of Crk in lens development, they also raise an interesting question regarding the nature of Ras signaling in this process. Previous studies have shown that the Frs2/Shp2 mediated Ras-MAPK pathway acts downstream of FGF signaling to regulate lens fiber cell differentiation (<xref ref-type="bibr" rid="bib33">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">Madakashira et al., 2012</xref>; <xref ref-type="bibr" rid="bib72">Upadhya et al., 2013</xref>), but in this study, our genetic evidence demonstrated that the Crk-mediated Ras signaling pathway only promoted fiber cell elongation and not differentiation. The uncoupling of lens fiber cell differentiation and elongation have been previously observed in lens explants, where pharmacological inhibition of ERK suppressed the morphological changes induced by FGF signaling while not preventing the expression of differentiation markers such as β-crystallin (<xref ref-type="bibr" rid="bib37">Lovicu and McAvoy, 2001</xref>). We propose that these results reveal a biphasic function of Ras signaling, which promotes either differentiation or elongation of lens cells in a dosage dependent manner. In this model, Ras signaling induced directly by the Frs2/Shp2/Grb2 complex is sufficient to stimulate cell differentiation, with the additional elevation of Ras activity potentiated by the binding of Crk proteins to the signaling complex resulting in the necessary promotion of cell shape changes. In support of this idea, we note that the loss of Crk proteins did not completely squelch Ras-MAPK signaling, allowing cell differentiation to proceed in <italic>Crk</italic> mutant lenses. Therefore, in response to heightened FGF signaling, Crk proteins act as additional boosters to Ras activity that results in the specific promotion of cell shape changes.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Crk<sup>flox</sup>, CrkL<sup>flox</sup></italic></td><td>PMID: 19074029</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3830069">MGI:3830069</ext-link></td><td>Dr. Tom Curran (The Children's Research Institute, Children's Mercy Kansas City)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgfr3<sup>flox</sup></italic></td><td>PMID: 20582225</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:4459834">MGI:4459834</ext-link></td><td>Dr. Xin Sun (University of California San Diego)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Frs2α<sup>flox</sup></italic></td><td>PMID: 17868091</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3768915">MGI:3768915</ext-link></td><td>Dr. Feng Wang (Texas A and M)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Rap1a<sup>flox</sup>, Rap1b<sup>flox</sup></italic></td><td>PMID: 18305243</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3777607">MGI:3777607</ext-link></td><td>Alexei Morozov (National Institutes of Health)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Shp2<sup>flox</sup></italic></td><td>PMID: 15520383</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3522138">MGI:3522138</ext-link></td><td>Gen-Sheng Feng (UCSD)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgf3<sup>OVE391</sup></italic></td><td>PMID: 7539358</td><td/><td>Dr. Michael Robinson (Miami University)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgf3<sup>OVE393A</sup></italic></td><td>PMID: 9640329</td><td/><td>Dr. Michael Robinson (Miami University)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgfr1</italic><sup>Δ<italic>Frs</italic></sup></td><td>PMID: 16421190</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3620075">MGI:3620075</ext-link></td><td>Dr. Raj Ladher (RIKEN Kobe Institute-Center for Developmental Biology)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgfr1<sup>Crk</sup></italic></td><td>PMID: 26341559</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:5882534">MGI:5882534</ext-link></td><td>Dr. Philipo Soriano (Washington University Medical School)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgfr2<sup>flox</sup></italic></td><td>PMID: 12756187</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3044690">MGI:3044690</ext-link></td><td>Dr. David Ornitz (Washington University Medical School)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgfr4<sup>-/-</sup></italic></td><td>PMID: 9716527</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3653043">MGI:3653043</ext-link></td><td>Dr. Chu-Xia Deng (National Institute of Health)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Grb2<sup>flox</sup></italic></td><td>PMID: 21427701</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:4949890">MGI:4949890</ext-link></td><td>Dr. Lars Nitschke (University of Erlangen-Nürnberg)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Pax6<sup>Le</sup>-Cre</italic> (<italic>Le-Cre</italic>)</td><td>PMID: 11069887</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3045795">MGI:3045795</ext-link></td><td>Dr. Ruth Ashery-Padan (Tel Aviv University)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Rac1<sup>flox</sup></italic></td><td>PMID: 12759446</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:2663672">MGI:2663672</ext-link></td><td>Dr. Feng-Chun Yang (Indiana University School of Medicine)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Rac2<sup>-/-</sup></italic></td><td>PMID: 10072071</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3840460">MGI:3840460</ext-link></td><td>Dr. Feng-Chun Yang (Indiana University School of Medicine)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Kras<sup>LSL-G12D</sup></italic></td><td>PMID: 15093544</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3044567">MGI:3044567</ext-link></td><td>Mouse Models of Human Cancers Consortium Repository at National Cancer Institute</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>Fgfr1<sup>flox</sup></italic></td><td>Jackson Laboratory</td><td>Stock #: 007671 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3713779">MGI:3713779</ext-link></td><td>PMID:16421190</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>R26-Rac1<sup>LSL-G12V</sup></italic></td><td>Jackson Laboratory</td><td>Stock #: 012361 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:4430563">MGI:4430563</ext-link></td><td>PMID:19879843</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td valign="bottom"><italic>ROSA<sup>mTmG</sup></italic></td><td>Jackson Laboratory</td><td>Stock #: 007676 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3722405">MGI:3722405</ext-link></td><td>PMID:17868096</td></tr><tr><td>Cell line(<italic>M. musculus</italic>)</td><td>NIH-3T3</td><td>American Type Culture Collection</td><td>Cat# CRL-1658, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0594">CVCL_0594</ext-link></td><td/></tr><tr><td>Transfected construct (synthesized)</td><td>TAP-CrkL</td><td>PMID: 26527617</td><td/><td>David J. Glass</td></tr><tr><td>Antibody</td><td>Rabbit anti-C-maf</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-7866 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_638562">AB_638562</ext-link></td><td>IHC (1:200)</td></tr><tr><td>Antibody</td><td>Rabbit anti-CrkL</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-319 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_631320">AB_631320</ext-link></td><td>IHC (1:100), WB (1:1000)</td></tr><tr><td>Antibody</td><td>Mouse anti-CrkL</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-365471</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Mouse anti-E-cadherin</td><td>Sigma</td><td>Cat. #: U3254</td><td>IHC (1:200)</td></tr><tr><td>Antibody</td><td>Rabbit anti-Frs2</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-8318 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2106228">AB_2106228</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-Grb2</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-255 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_631602">AB_631602</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-Jag1</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-6011 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_649689">AB_649689</ext-link></td><td>IHC (1:100)</td></tr><tr><td>Antibody</td><td>Mouse anti-Ki-67</td><td>BD Pharmingen</td><td>Cat. #: 550609 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_393778">AB_393778</ext-link></td><td>IHC (1:200)</td></tr><tr><td>Antibody</td><td>Rabbit anti-p57</td><td>Abcam</td><td>Cat. #: ab75974</td><td>IHC (1:2000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-Pax6</td><td>Covance</td><td>Cat. #: PRB-278P <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_291612">AB_291612</ext-link></td><td>IHC (1:500)</td></tr><tr><td>Antibody</td><td>Rabbit anti-pCrk (Tyr221)</td><td>Cell Signaling</td><td>Cat. #: 3491</td><td>IHC (1:200), WB (1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-pCrkL (Tyr207)</td><td>Cell Signaling</td><td>Cat. #: 3181</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-pERK1/2</td><td>Cell Signaling</td><td>Cat. #: 4370</td><td>IHC (1:200), WB (1:1000)</td></tr><tr><td>Antibody</td><td>Mouse anti-pERK1/2</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-7383</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-Prox1</td><td>Covance</td><td>Cat. No.: PRB-238C</td><td>IHC (1:1000)</td></tr><tr><td>Antibody</td><td>Mouse anti-Rac1</td><td>BD Transduction Laboratory</td><td>Cat. #: 610652 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_397979">AB_397979</ext-link></td><td>IHC (1:200)</td></tr><tr><td>Antibody</td><td>Rabbit anti-Shp2</td><td>Santa Cruz Biotechnology</td><td>Cat. #: sc-280 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_632401">AB_632401</ext-link></td><td>IHC (1:100), WB (1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-α-crystallin</td><td>Sam Zigler (National Eye Institute)</td><td/><td>IHC (1:5000)</td></tr><tr><td>Antibody</td><td>Mouse anti-α-SMA</td><td>Sigma</td><td>Cat. #: C6198</td><td>IHC (1:1000)</td></tr><tr><td>Antibody</td><td>Mouse anti-β-catenin</td><td>Sigma</td><td>Cat. #: 6F9</td><td>IHC (1:200)</td></tr><tr><td>Antibody</td><td>Rabbit anti-β-crystallin</td><td>Sam Zigler (National Eye Institute)</td><td/><td>IHC (1:5000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-γ-crystallin</td><td>Sam Zigler (National Eye Institute)</td><td/><td>IHC (1:5000)</td></tr><tr><td>Recombinant DNA reagent</td><td>Ad5CMVCre-eGFP</td><td>Gene Transfer Vector Core, University of Iowa, IA</td><td>VVC-U of Iowa-1174</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>Ad5CMVeGFP</td><td>Gene Transfer Vector Core, University of Iowa, IA</td><td>VVC-U of Iowa-4</td><td/></tr><tr><td>Peptide, recombinant protein</td><td>recombinant human FGF2</td><td>ScienCell</td><td>104–02</td><td/></tr><tr><td>Peptide, recombinant protein</td><td>recombinant murine FGF2</td><td>ScienCell</td><td>124–02</td><td/></tr><tr><td>Commercial assay or kit</td><td>In situ cell death detection kit, Fluorescein</td><td>Sigma</td><td>11684795910 ROCHE</td><td/></tr><tr><td>Commercial assay or kit</td><td>streptavidin resin</td><td>Agilent</td><td>240207</td><td/></tr><tr><td>Chemical compound, drug</td><td>Alexa Fluor 488 Phalloidin</td><td>ThermoFisher Scientific</td><td>A12379</td><td>1:50</td></tr><tr><td>Chemical compound, drug</td><td>heparin sodium</td><td>Sigma</td><td>H3393</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>Mice carrying <italic>Crk<sup>flox</sup>, Crkl<sup>flox</sup></italic>, <italic>Fgfr3<sup>flox</sup>, Frs2α<sup>flox</sup></italic>, <italic>Rap1a<sup>flox</sup>, Rap1b<sup>flox</sup></italic> and <italic>Shp2<sup>flox</sup></italic> alleles were bred and genotyped as described (<xref ref-type="bibr" rid="bib34">Lin et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Pan et al., 2008</xref>; <xref ref-type="bibr" rid="bib50">Park and Curran, 2008</xref>; <xref ref-type="bibr" rid="bib66">Su et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Zhang et al., 2004</xref>). <italic>Fgf3<sup>OVE391</sup></italic> and <italic>Fgf3<sup>OVE393A</sup></italic> were from Dr. Michael Robinson (Miami University, Oxford, OH), <italic>Fgfr1<sup>ΔFrs</sup></italic> from Dr. Raj Ladher (RIKEN Kobe Institute-Center for Developmental Biology, Kobe, Japan), <italic>Fgfr1<sup>Crk</sup></italic> from Dr. Philipo Soriano (Washington University Medical School, St Louis, MO), <italic>Fgfr2<sup>flox</sup></italic> from Dr. David Ornitz (Washington University Medical School, St Louis, MO), <italic>Fgfr3<sup>flox</sup></italic> from Dr. Xin Sun (University of California San Diego, La Jolla, CA), <italic>Fgfr4<sup>-/-</sup></italic> from Dr. Chu-Xia Deng (National Institute of Health, Bethesda, MD), <italic>Grb2<sup>flox</sup></italic> from Dr. Lars Nitschke (University of Erlangen-Nürnberg, Erlangen, Germany), <italic>Pax6<sup>Le</sup>-Cre</italic> (<italic>Le-Cre</italic>) from Drs. Ruth Ashery-Padan (Tel Aviv University, Tel Aviv, Israel) and Richard Lang (Children's Hospital Research Foundation, Cincinnati, OH), <italic>Rac1<sup>flox</sup></italic> and <italic>Rac2<sup>-/-</sup></italic> from Dr. Feng-Chun Yang (Indiana University School of Medicine, Indianapolis, IN) (<xref ref-type="bibr" rid="bib1">Ackermann et al., 2011</xref>; <xref ref-type="bibr" rid="bib3">Ashery-Padan et al., 2000</xref>; <xref ref-type="bibr" rid="bib9">Brewer et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Glogauer et al., 2003</xref>; <xref ref-type="bibr" rid="bib26">Hoch and Soriano, 2006</xref>; <xref ref-type="bibr" rid="bib58">Roberts et al., 1999</xref>; <xref ref-type="bibr" rid="bib59">Robinson et al., 1998</xref>; <xref ref-type="bibr" rid="bib74">Weinstein et al., 1998</xref>; <xref ref-type="bibr" rid="bib76">Yu et al., 2003</xref>). <italic>Kras<sup>LSL-G12D</sup></italic> mice were obtained from the Mouse Models of Human Cancers Consortium (MMHCC) Repository at National Cancer Institute (<xref ref-type="bibr" rid="bib71">Tuveson et al., 2004</xref>). <italic>Fgfr1<sup>flox</sup></italic> (Stock No: 007671), <italic>R26-Rac1<sup>LSL-G12V</sup></italic> (Stock No: 012361) and <italic>ROSA<sup>mTmG</sup></italic> (Stock No: 007676) mice were obtained from Jackson Laboratory (<xref ref-type="bibr" rid="bib26">Hoch and Soriano, 2006</xref>; <xref ref-type="bibr" rid="bib44">Muzumdar et al., 2007</xref>; <xref ref-type="bibr" rid="bib65">Srinivasan et al., 2009</xref>). In all conditional knockout experiments, mice were maintained on a mixed genetic background and at least three animals were analyzed for each genotype (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We did not observe phenotypic variation in lens development among <italic>Pax6<sup>Le</sup>-Cre</italic> and <italic>Pax6<sup>Le</sup>-Cre;Crk<sup>floxl+</sup>;Crkl<sup>flox/+</sup></italic> mice, and thus <italic>Pax6<sup>Le</sup>-Cre</italic> only mice were used as controls. Mouse maintenance and experimentation was performed according to protocols approved by Columbia University Institutional Animal Care and Use Committee.</p></sec><sec id="s4-2"><title>Histology, Immunohistochemistry, Immunocytochemistry</title><p>Mouse embryos were fixed with 4% paraformaldehyde (PFA) in PBS overnight and paraffin or cryo embedded. The paraffin sections (10 µm) were rehydrated and stained with hematoxylin and eosin (H and E) for histological analysis. Lens sizes were measured as previously described (<xref ref-type="bibr" rid="bib11">Cai et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Pan et al., 2010</xref>). TUNEL staining and immunostaining were performed on the cryosections (8 µm) as previously described (<xref ref-type="bibr" rid="bib12">Carbe et al., 2012</xref>; <xref ref-type="bibr" rid="bib13">Carbe and Zhang, 2011</xref>). For phospho-ERK and Shp2 staining, the signal was amplified using a Tyramide Signal Amplification kit (TSA Plus System, PerkinElmer Life Sciences, Waltham, MA). Antibodies used were: anti-Shp2 (Sc-280), anti-C-maf (sc-7866), anti-Crkl (Sc-319), anti-Jag1 (Sc-6011) (all from Santa Cruz Biotechnology, Santa Cruz, CA), anti-pCrkl (Tyr207) (#3181, also recognize pCrk (Tyr221) and anti-pERK1/2 (#4370) (both from Cell Signaling Technology, Boston, MA), anti-P57 (ab75974, from Abcam, Boston, MA), anti-α-SMA (#C6198), anti-β-catenin (6F9), anti-E-cadherin (U3254) (all from Sigma, St. Louis, MO), anti-Ki67 (#550609, BD Pharmingen, San Jose, CA), anti-Crk (#610036), anti-Rac1 (#610651) (both from BD Transduction Laboratory, Franklin Lakes, NJ), anti-Prox1 (PRB-238C) and anti-Pax6 (PRB-278P) (both from Covance, San Diego, CA). Antibodies against α-, β- and γ-crystallins were kindly provided by Sam Zigler (National Eye Institute). Cell proliferation and apoptosis were measured as the ratio of Ki67 or TUNEL-positive cells versus DAPI-positive cells, and analyzed by one-way ANOVA analysis. Alexa Fluor 488 Phalloidin (A12379, ThermoFisher) was used to stain F-actin.</p></sec><sec id="s4-3"><title>Lens epithelium explant culture</title><p>Postnatal day 0 to day 3 <italic>Crk<sup>flox/flox</sup>;Crkl<sup>floxflox</sup></italic> mice were sacrificed and eyes enucleated. Lenses were then dissected out in lens explant culture medium containing DMEM with 1% BSA (BP1600, Fisher Scientific) and 1:100 dilution of Antibiotic-Antimycotic (15240062, ThermoFisher). Lens capsules were torn open from the posterior before the lens epithelium was peeled off with forceps and pinned down onto a cell culture dish. To delete Crk and Crkl in the lens explants, 2 × 10<sup>7</sup> adenoviruses expressing Cre recombinase (Ad5CMVCre-eGFP, Cat #: VVC-U of Iowa-1174, Gene Transfer Vector Core, University of Iowa, IA) were added to the culture of 4 explants for 8 hr one day after explant isolation. GFP-expressing adenoviruses (Ad5CMVeGFP, Cat #: VVC-U of Iowa-4) were used as a control. To induce fiber cell differentiation and elongation, these explants were further cultured in the lens explant culture medium with 2 mg/ml heparin sodium (H3393, Sigma) and 100 ng/ml recombinant murine FGF2 (124–02, ScienCell, Carlsbad, CA ) for 4–5 days.</p></sec><sec id="s4-4"><title>Cell protein extract isolation and western blots</title><p>4.24–6.36 × 10<sup>5</sup> MEF cells infected with Ad5CMVCre were seeded in 60 mm dishes and serum starved (0.5% FBS in DMEM) for 36–48 hr before being stimulated by 50 ng/ml FGF2 (R and D Systems, Minneapolis, MN) for 5 min at 37°C as previously described (<xref ref-type="bibr" rid="bib33">Li et al., 2014</xref>). After washing twice in cold PBS, MEF cells were lysed in 160 µl RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 µg/ml aprotinin, 1 µg/ml pepstatin, 10 mM sodium pyrophosphate, 1 mM PMSF, 0.2 mM Na<sub>3</sub>VO<sub>4</sub>, 50 mM NaF). Proteins were visualized by infrared-based western blot analysis using an Odyssey SA scanner (LICOR Biosciences, Lincoln, NE). The signal intensity was quantified using the Odyssey software. The antibodies used were mouse anti-phospho-ERK1/2 (sc-7383, Santa Cruz Biotechnology), anti-phospho-Crk (tyr221) (#3491, Cell Signaling Technology), rabbit-anti-Crkl (sc-319, Santa Cruz biotechnology), mouse-anti-Crkl (sc-365471, Santa Cruz biotechnology), anti-Shp2 (sc-280, Santa Cruz biotechnology), anti-Grb2 (sc-255, Santa Cruz biotechnology), and anti-Frs2 (sc-8318, Santa Cruz biotechnology).</p></sec><sec id="s4-5"><title>Immunoprecipitation</title><p>NIH3T3 cells from the American Type Culture Collection were tested mycoplasma-free. They were plated at 1 × 10<sup>6</sup> cell per 10 cm tissue culture plate and transfected with 2.5 μg TAP-Crkl plasmid (<xref ref-type="bibr" rid="bib23">Hallock et al., 2015</xref>) using lipofectamine 3000 (ThermoFisher, Springfield Township, NJ). 36 hr after the transfection, cells were serum depleted overnight and then were treated with 100 ng/ml recombinant human FGF2 (104–02, ScienCell) for 5 min. Both the treatment group and control were lysed with 1 ml immunoprecipitation buffer (25 mM Tris-HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% NP-40, 5% glycerol) supplemented with Halt protease inhibitor cocktail (ThermoFisher). Lysates were then incubated with streptavidin resins (240207, Agilent, Santa Clara, CA) to pull down TAP-Crkl, according to manufacturer’s recommendations. Resins were later washed in streptavidin binding buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl) twice at 4°C. All pulled-down proteins were eluted in 1X Laemmli SDS sample buffer (1.5% SDS, 9% glycerol, 62.5 mM Tris-HCl, pH 6.8, 0.00025% Bromophenol blue, 2% β-mercaptoethanol). Samples were denatured at 95°C for 5 min before being loaded onto SDS-PAGE gels.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors thank Drs. Chu-Xia Deng, Raj Ladher, Richard Lang, Alexei Morozov, Lars Nitschke, David Ornitz, Ruth Ashery-Padan, Philippe Soriano and Feng-Chun Yang for mice. We also thank Drs. Frank Lovicu and Judith West-Mays for advice on lens explant culture. The work was supported by NIH (EY017061 to XZ). The Columbia Ophthalmology Core Facility is supported by NIH Core grant 5P30EY019007 and unrestricted funds from Research to Prevent Blindness (RPB). Xin Zhang is supported by Jules and Doris Stein Research to Prevent Blindness Professorship. Tamica Collins is a recipient of Edwin T Harper Scholarship.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Mouse maintenance and experimentation was performed according to protocols approved by Columbia University Institutional Animal Care and Use Committee (protocol AAAR0429).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.32586.015</object-id><label>Supplementary file 1.</label><caption><title>List of genetic crosses and experimental progenies.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-32586-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.32586.016</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-32586-transrepform-v2.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackermann</surname> <given-names>JA</given-names></name><name><surname>Radtke</surname> <given-names>D</given-names></name><name><surname>Maurberger</surname> <given-names>A</given-names></name><name><surname>Winkler</surname> <given-names>TH</given-names></name><name><surname>Nitschke</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Grb2 regulates B-cell maturation, B-cell memory responses and inhibits B-cell Ca2+ signalling</article-title><source>The EMBO Journal</source><volume>30</volume><fpage>1621</fpage><lpage>1633</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.74</pub-id><pub-id pub-id-type="pmid">21427701</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoku</surname> <given-names>S</given-names></name><name><surname>Mayer</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals</article-title><source>Journal of Cell Science</source><volume>122</volume><fpage>4228</fpage><lpage>4238</lpage><pub-id pub-id-type="doi">10.1242/jcs.054627</pub-id><pub-id pub-id-type="pmid">19861495</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashery-Padan</surname> <given-names>R</given-names></name><name><surname>Marquardt</surname> <given-names>T</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Gruss</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye</article-title><source>Genes &amp; Development</source><volume>14</volume><fpage>2701</fpage><lpage>2711</lpage><pub-id pub-id-type="doi">10.1101/gad.184000</pub-id><pub-id pub-id-type="pmid">11069887</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audette</surname> <given-names>DS</given-names></name><name><surname>Anand</surname> <given-names>D</given-names></name><name><surname>So</surname> <given-names>T</given-names></name><name><surname>Rubenstein</surname> <given-names>TB</given-names></name><name><surname>Lachke</surname> <given-names>SA</given-names></name><name><surname>Lovicu</surname> <given-names>FJ</given-names></name><name><surname>Duncan</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prox1 and fibroblast growth factor receptors form a novel regulatory loop controlling lens fiber differentiation and gene expression</article-title><source>Development</source><volume>143</volume><fpage>318</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1242/dev.127860</pub-id><pub-id pub-id-type="pmid">26657765</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audette</surname> <given-names>DS</given-names></name><name><surname>Scheiblin</surname> <given-names>DA</given-names></name><name><surname>Duncan</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The molecular mechanisms underlying lens fiber elongation</article-title><source>Experimental Eye Research</source><volume>156</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2016.03.016</pub-id><pub-id pub-id-type="pmid">27015931</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassnett</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Three-dimensional reconstruction of cells in the living lens: the relationship between cell length and volume</article-title><source>Experimental Eye Research</source><volume>81</volume><fpage>716</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2005.04.009</pub-id><pub-id pub-id-type="pmid">15963502</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beebe</surname> <given-names>DC</given-names></name><name><surname>Feagans</surname> <given-names>DE</given-names></name><name><surname>Blanchette-Mackie</surname> <given-names>EJ</given-names></name><name><surname>Nau</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Lens epithelial cell elongation in the absence of microtubules: evidence for a new effect of colchicine</article-title><source>Science</source><volume>206</volume><fpage>836</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1126/science.493982</pub-id><pub-id pub-id-type="pmid">493982</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birge</surname> <given-names>RB</given-names></name><name><surname>Kalodimos</surname> <given-names>C</given-names></name><name><surname>Inagaki</surname> <given-names>F</given-names></name><name><surname>Tanaka</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Crk and CrkL adaptor proteins: networks for physiological and pathological signaling</article-title><source>Cell Communication and Signaling</source><volume>7</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.1186/1478-811X-7-13</pub-id><pub-id pub-id-type="pmid">19426560</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewer</surname> <given-names>JR</given-names></name><name><surname>Molotkov</surname> <given-names>A</given-names></name><name><surname>Mazot</surname> <given-names>P</given-names></name><name><surname>Hoch</surname> <given-names>RV</given-names></name><name><surname>Soriano</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fgfr1 regulates development through the combinatorial use of signaling proteins</article-title><source>Genes &amp; Development</source><volume>29</volume><fpage>1863</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1101/gad.264994.115</pub-id><pub-id pub-id-type="pmid">26341559</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byers</surname> <given-names>B</given-names></name><name><surname>Porter</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="1964">1964</year><article-title>Oriented microtubules in elongating cells of the developing lens rudiment after induction</article-title><source>PNAS</source><volume>52</volume><fpage>1091</fpage><lpage>1099</lpage><pub-id pub-id-type="doi">10.1073/pnas.52.4.1091</pub-id><pub-id pub-id-type="pmid">14224388</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>Z</given-names></name><name><surname>Simons</surname> <given-names>DL</given-names></name><name><surname>Fu</surname> <given-names>XY</given-names></name><name><surname>Feng</surname> <given-names>GS</given-names></name><name><surname>Wu</surname> <given-names>SM</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Loss of Shp2-mediated mitogen-activated protein kinase signaling in Muller glial cells results in retinal degeneration</article-title><source>Molecular and Cellular Biology</source><volume>31</volume><fpage>2973</fpage><lpage>2983</lpage><pub-id pub-id-type="doi">10.1128/MCB.05054-11</pub-id><pub-id pub-id-type="pmid">21576358</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbe</surname> <given-names>C</given-names></name><name><surname>Hertzler-Schaefer</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The functional role of the Meis/Prep-binding elements in Pax6 locus during pancreas and eye development</article-title><source>Developmental Biology</source><volume>363</volume><fpage>320</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.12.038</pub-id><pub-id pub-id-type="pmid">22240097</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbe</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lens induction requires attenuation of ERK signaling by Nf1</article-title><source>Human Molecular Genetics</source><volume>20</volume><fpage>1315</fpage><lpage>1323</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr014</pub-id><pub-id pub-id-type="pmid">21233129</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname> <given-names>BK</given-names></name><name><surname>Lou</surname> <given-names>M</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Lang</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Balanced Rac1 and RhoA activities regulate cell shape and drive invagination morphogenesis in epithelia</article-title><source>PNAS</source><volume>108</volume><fpage>18289</fpage><lpage>18294</lpage><pub-id pub-id-type="doi">10.1073/pnas.1108993108</pub-id><pub-id pub-id-type="pmid">22021442</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cvekl</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Signaling and gene regulatory networks in mammalian lens development</article-title><source>Trends in Genetics</source><volume>33</volume><fpage>677</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.08.001</pub-id><pub-id pub-id-type="pmid">28867048</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feller</surname> <given-names>SM</given-names></name><name><surname>Knudsen</surname> <given-names>B</given-names></name><name><surname>Hanafusa</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>c-Abl kinase regulates the protein binding activity of c-Crk</article-title><source>The EMBO Journal</source><volume>13</volume><fpage>2341</fpage><lpage>2351</lpage><pub-id pub-id-type="pmid">8194526</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feller</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Crk family adaptors-signalling complex formation and biological roles</article-title><source>Oncogene</source><volume>20</volume><fpage>6348</fpage><lpage>6371</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1204779</pub-id><pub-id pub-id-type="pmid">11607838</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname> <given-names>CM</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Madakashira</surname> <given-names>BP</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Rajagopal</surname> <given-names>R</given-names></name><name><surname>Dattilo</surname> <given-names>L</given-names></name><name><surname>Robinson</surname> <given-names>ML</given-names></name><name><surname>Beebe</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The function of FGF signaling in the lens placode</article-title><source>Developmental Biology</source><volume>351</volume><fpage>176</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.01.001</pub-id><pub-id pub-id-type="pmid">21223962</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname> <given-names>B</given-names></name><name><surname>Fan</surname> <given-names>Q</given-names></name><name><surname>Dlugos</surname> <given-names>CP</given-names></name><name><surname>Soofi</surname> <given-names>AA</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Verma</surname> <given-names>R</given-names></name><name><surname>Park</surname> <given-names>TJ</given-names></name><name><surname>Wong</surname> <given-names>H</given-names></name><name><surname>Curran</surname> <given-names>T</given-names></name><name><surname>Nihalani</surname> <given-names>D</given-names></name><name><surname>Holzman</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis</article-title><source>Kidney International</source><volume>85</volume><fpage>1382</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1038/ki.2013.556</pub-id><pub-id pub-id-type="pmid">24499776</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloerich</surname> <given-names>M</given-names></name><name><surname>Bos</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulating Rap small G-proteins in time and space</article-title><source>Trends in Cell Biology</source><volume>21</volume><fpage>615</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2011.07.001</pub-id><pub-id pub-id-type="pmid">21820312</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glogauer</surname> <given-names>M</given-names></name><name><surname>Marchal</surname> <given-names>CC</given-names></name><name><surname>Zhu</surname> <given-names>F</given-names></name><name><surname>Worku</surname> <given-names>A</given-names></name><name><surname>Clausen</surname> <given-names>BE</given-names></name><name><surname>Foerster</surname> <given-names>I</given-names></name><name><surname>Marks</surname> <given-names>P</given-names></name><name><surname>Downey</surname> <given-names>GP</given-names></name><name><surname>Dinauer</surname> <given-names>M</given-names></name><name><surname>Kwiatkowski</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions</article-title><source>The Journal of Immunology</source><volume>170</volume><fpage>5652</fpage><lpage>5657</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.170.11.5652</pub-id><pub-id pub-id-type="pmid">12759446</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunhaga</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The lens: a classical model of embryonic induction providing new insights into cell determination in early development</article-title><source>Philosophical Transactions of the Royal Society B: Biological Sciences</source><volume>366</volume><fpage>1193</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1098/rstb.2010.0175</pub-id><pub-id pub-id-type="pmid">21402580</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallock</surname> <given-names>PT</given-names></name><name><surname>Chin</surname> <given-names>S</given-names></name><name><surname>Blais</surname> <given-names>S</given-names></name><name><surname>Neubert</surname> <given-names>TA</given-names></name><name><surname>Glass</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sorbs1 and -2 interact with CrkL and are required for acetylcholine receptor cluster formation</article-title><source>Molecular and Cellular Biology</source><volume>36</volume><fpage>262</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1128/MCB.00775-15</pub-id><pub-id pub-id-type="pmid">26527617</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallock</surname> <given-names>PT</given-names></name><name><surname>Xu</surname> <given-names>CF</given-names></name><name><surname>Park</surname> <given-names>TJ</given-names></name><name><surname>Neubert</surname> <given-names>TA</given-names></name><name><surname>Curran</surname> <given-names>T</given-names></name><name><surname>Burden</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L</article-title><source>Genes &amp; Development</source><volume>24</volume><fpage>2451</fpage><lpage>2461</lpage><pub-id pub-id-type="doi">10.1101/gad.1977710</pub-id><pub-id pub-id-type="pmid">21041412</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname> <given-names>H</given-names></name><name><surname>Kiyokawa</surname> <given-names>E</given-names></name><name><surname>Tanaka</surname> <given-names>S</given-names></name><name><surname>Nagashima</surname> <given-names>K</given-names></name><name><surname>Gotoh</surname> <given-names>N</given-names></name><name><surname>Shibuya</surname> <given-names>M</given-names></name><name><surname>Kurata</surname> <given-names>T</given-names></name><name><surname>Matsuda</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane</article-title><source>Molecular and Cellular Biology</source><volume>16</volume><fpage>1770</fpage><lpage>1776</lpage><pub-id pub-id-type="doi">10.1128/MCB.16.4.1770</pub-id><pub-id pub-id-type="pmid">8657152</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoch</surname> <given-names>RV</given-names></name><name><surname>Soriano</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development</article-title><source>Development</source><volume>133</volume><fpage>663</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1242/dev.02242</pub-id><pub-id pub-id-type="pmid">16421190</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Clarke</surname> <given-names>F</given-names></name><name><surname>Karimi</surname> <given-names>M</given-names></name><name><surname>Roy</surname> <given-names>NH</given-names></name><name><surname>Williamson</surname> <given-names>EK</given-names></name><name><surname>Okumura</surname> <given-names>M</given-names></name><name><surname>Mochizuki</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>EJ</given-names></name><name><surname>Park</surname> <given-names>TJ</given-names></name><name><surname>Debes</surname> <given-names>GF</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Curran</surname> <given-names>T</given-names></name><name><surname>Kambayashi</surname> <given-names>T</given-names></name><name><surname>Burkhardt</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CRK proteins selectively regulate T cell migration into inflamed tissues</article-title><source>Journal of Clinical Investigation</source><volume>125</volume><fpage>1019</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1172/JCI77278</pub-id><pub-id pub-id-type="pmid">25621495</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname> <given-names>S</given-names></name><name><surname>Jaiswal</surname> <given-names>RK</given-names></name><name><surname>Kolch</surname> <given-names>W</given-names></name><name><surname>Landreth</surname> <given-names>GE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>18169</fpage><lpage>18177</lpage><pub-id pub-id-type="doi">10.1074/jbc.M008870200</pub-id><pub-id pub-id-type="pmid">11278445</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klint</surname> <given-names>P</given-names></name><name><surname>Claesson-Welsh</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Signal transduction by fibroblast growth factor receptors</article-title><source>Frontiers in Bioscience</source><volume>4</volume><fpage>d165</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.2741/Klint</pub-id><pub-id pub-id-type="pmid">9989949</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korol</surname> <given-names>A</given-names></name><name><surname>Pino</surname> <given-names>G</given-names></name><name><surname>Dwivedi</surname> <given-names>D</given-names></name><name><surname>Robertson</surname> <given-names>JV</given-names></name><name><surname>Deschamps</surname> <given-names>PA</given-names></name><name><surname>West-Mays</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Matrix metalloproteinase-9-null mice are resistant to TGF-β-induced anterior subcapsular cataract formation</article-title><source>The American Journal of Pathology</source><volume>184</volume><fpage>2001</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2014.03.013</pub-id><pub-id pub-id-type="pmid">24814605</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouhara</surname> <given-names>H</given-names></name><name><surname>Hadari</surname> <given-names>YR</given-names></name><name><surname>Spivak-Kroizman</surname> <given-names>T</given-names></name><name><surname>Schilling</surname> <given-names>J</given-names></name><name><surname>Bar-Sagi</surname> <given-names>D</given-names></name><name><surname>Lax</surname> <given-names>I</given-names></name><name><surname>Schlessinger</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway</article-title><source>Cell</source><volume>89</volume><fpage>693</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80252-4</pub-id><pub-id pub-id-type="pmid">9182757</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname> <given-names>H</given-names></name><name><surname>Klint</surname> <given-names>P</given-names></name><name><surname>Landgren</surname> <given-names>E</given-names></name><name><surname>Claesson-Welsh</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><fpage>25726</fpage><lpage>25734</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.36.25726</pub-id><pub-id pub-id-type="pmid">10464310</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Tao</surname> <given-names>C</given-names></name><name><surname>Cai</surname> <given-names>Z</given-names></name><name><surname>Hertzler-Schaefer</surname> <given-names>K</given-names></name><name><surname>Collins</surname> <given-names>TN</given-names></name><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Feng</surname> <given-names>GS</given-names></name><name><surname>Gotoh</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Frs2α and Shp2 signal independently of Gab to mediate FGF signaling in lens development</article-title><source>Journal of Cell Science</source><volume>127</volume><fpage>571</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1242/jcs.134478</pub-id><pub-id pub-id-type="pmid">24284065</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Generation of an Frs2alpha conditional null allele</article-title><source>Genesis</source><volume>45</volume><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1002/dvg.20327</pub-id><pub-id pub-id-type="pmid">17868091</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname> <given-names>WK</given-names></name><name><surname>Wen</surname> <given-names>XJ</given-names></name><name><surname>Zhou</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Microtubule configuration and membranous vesicle transport in elongating fiber cells of the rat lens</article-title><source>Experimental Eye Research</source><volume>77</volume><fpage>615</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1016/S0014-4835(03)00176-3</pub-id><pub-id pub-id-type="pmid">14550404</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname> <given-names>CM</given-names></name><name><surname>Rajakaruna</surname> <given-names>S</given-names></name><name><surname>Bowen</surname> <given-names>C</given-names></name><name><surname>Radice</surname> <given-names>GL</given-names></name><name><surname>Robinson</surname> <given-names>ML</given-names></name><name><surname>Menko</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>N-cadherin regulates signaling mechanisms required for lens fiber cell elongation and lens morphogenesis</article-title><source>Developmental Biology</source><volume>428</volume><fpage>118</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2017.05.022</pub-id><pub-id pub-id-type="pmid">28552735</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovicu</surname> <given-names>FJ</given-names></name><name><surname>McAvoy</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>FGF-induced lens cell proliferation and differentiation is dependent on MAPK (ERK1/2) signalling</article-title><source>Development</source><volume>128</volume><fpage>5075</fpage><lpage>5084</lpage><pub-id pub-id-type="pmid">11748143</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madakashira</surname> <given-names>BP</given-names></name><name><surname>Kobrinski</surname> <given-names>DA</given-names></name><name><surname>Hancher</surname> <given-names>AD</given-names></name><name><surname>Arneman</surname> <given-names>EC</given-names></name><name><surname>Wagner</surname> <given-names>BD</given-names></name><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Shin</surname> <given-names>H</given-names></name><name><surname>Lovicu</surname> <given-names>FJ</given-names></name><name><surname>Reneker</surname> <given-names>LW</given-names></name><name><surname>Robinson</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Frs2α enhances fibroblast growth factor-mediated survival and differentiation in lens development</article-title><source>Development</source><volume>139</volume><fpage>4601</fpage><lpage>4612</lpage><pub-id pub-id-type="doi">10.1242/dev.081737</pub-id><pub-id pub-id-type="pmid">23136392</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddala</surname> <given-names>R</given-names></name><name><surname>Chauhan</surname> <given-names>BK</given-names></name><name><surname>Walker</surname> <given-names>C</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Robinson</surname> <given-names>ML</given-names></name><name><surname>Lang</surname> <given-names>RA</given-names></name><name><surname>Rao</surname> <given-names>PV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival</article-title><source>Developmental Biology</source><volume>360</volume><fpage>30</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.09.004</pub-id><pub-id pub-id-type="pmid">21945075</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddala</surname> <given-names>R</given-names></name><name><surname>Nagendran</surname> <given-names>T</given-names></name><name><surname>Lang</surname> <given-names>RA</given-names></name><name><surname>Morozov</surname> <given-names>A</given-names></name><name><surname>Rao</surname> <given-names>PV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rap1 GTPase is required for mouse lens epithelial maintenance and morphogenesis</article-title><source>Developmental Biology</source><volume>406</volume><fpage>74</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2015.06.022</pub-id><pub-id pub-id-type="pmid">26212757</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAvoy</surname> <given-names>JW</given-names></name><name><surname>Chamberlain</surname> <given-names>CG</given-names></name><name><surname>de Iongh</surname> <given-names>RU</given-names></name><name><surname>Hales</surname> <given-names>AM</given-names></name><name><surname>Lovicu</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Lens development</article-title><source>Eye</source><volume>13</volume><fpage>425</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1038/eye.1999.117</pub-id><pub-id pub-id-type="pmid">10627820</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAvoy</surname> <given-names>JW</given-names></name><name><surname>Chamberlain</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Fibroblast growth factor (FGF) induces different responses in lens epithelial cells depending on its concentration</article-title><source>Development</source><volume>107</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">2632221</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname> <given-names>AM</given-names></name><name><surname>Guris</surname> <given-names>DL</given-names></name><name><surname>Seo</surname> <given-names>JH</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Hammond</surname> <given-names>J</given-names></name><name><surname>Talbot</surname> <given-names>A</given-names></name><name><surname>Imamoto</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes</article-title><source>Developmental Cell</source><volume>10</volume><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.12.003</pub-id><pub-id pub-id-type="pmid">16399079</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzumdar</surname> <given-names>MD</given-names></name><name><surname>Tasic</surname> <given-names>B</given-names></name><name><surname>Miyamichi</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A global double-fluorescent Cre reporter mouse</article-title><source>Genesis</source><volume>45</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/dvg.20335</pub-id><pub-id pub-id-type="pmid">17868096</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojima</surname> <given-names>Y</given-names></name><name><surname>Mimura</surname> <given-names>T</given-names></name><name><surname>Morino</surname> <given-names>N</given-names></name><name><surname>Hamasaki</surname> <given-names>K</given-names></name><name><surname>Furuya</surname> <given-names>H</given-names></name><name><surname>Sakai</surname> <given-names>R</given-names></name><name><surname>Nakamoto</surname> <given-names>T</given-names></name><name><surname>Yazaki</surname> <given-names>Y</given-names></name><name><surname>Hirai</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Tyrosine phosphorylation of p130Cas in cell adhesion and transformation</article-title><source>Human Cell</source><volume>9</volume><fpage>169</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">9183645</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname> <given-names>T</given-names></name><name><surname>Heaney</surname> <given-names>C</given-names></name><name><surname>Hagopian</surname> <given-names>JR</given-names></name><name><surname>Okuda</surname> <given-names>K</given-names></name><name><surname>Griffin</surname> <given-names>JD</given-names></name><name><surname>Druker</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia</article-title><source>The Journal of Biological Chemistry</source><volume>269</volume><fpage>22925</fpage><lpage>22928</lpage><pub-id pub-id-type="pmid">8083188</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>BX</given-names></name><name><surname>Vautier</surname> <given-names>F</given-names></name><name><surname>Ito</surname> <given-names>W</given-names></name><name><surname>Bolshakov</surname> <given-names>VY</given-names></name><name><surname>Morozov</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Enhanced cortico-amygdala efficacy and suppressed fear in absence of Rap1</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>2089</fpage><lpage>2098</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5156-07.2008</pub-id><pub-id pub-id-type="pmid">18305243</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>Y</given-names></name><name><surname>Carbe</surname> <given-names>C</given-names></name><name><surname>Powers</surname> <given-names>A</given-names></name><name><surname>Feng</surname> <given-names>GS</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development</article-title><source>Development</source><volume>137</volume><fpage>1085</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1242/dev.042820</pub-id><pub-id pub-id-type="pmid">20215346</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>TJ</given-names></name><name><surname>Boyd</surname> <given-names>K</given-names></name><name><surname>Curran</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cardiovascular and craniofacial defects in Crk-null mice</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>6272</fpage><lpage>6282</lpage><pub-id pub-id-type="doi">10.1128/MCB.00472-06</pub-id><pub-id pub-id-type="pmid">16880535</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>TJ</given-names></name><name><surname>Curran</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>13551</fpage><lpage>13562</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4323-08.2008</pub-id><pub-id pub-id-type="pmid">19074029</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathania</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Simirskii</surname> <given-names>VN</given-names></name><name><surname>Duncan</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>β1‐integrin controls cell fate specification in early lens development</article-title><source>Differentiation</source><volume>92</volume><fpage>133</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.diff.2016.08.002</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname> <given-names>V</given-names></name><name><surname>Boyer</surname> <given-names>B</given-names></name><name><surname>Lentz</surname> <given-names>D</given-names></name><name><surname>Turner</surname> <given-names>CE</given-names></name><name><surname>Thiery</surname> <given-names>JP</given-names></name><name><surname>Vallés</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells</article-title><source>The Journal of Cell Biology</source><volume>148</volume><fpage>957</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1083/jcb.148.5.957</pub-id><pub-id pub-id-type="pmid">10704446</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pontoriero</surname> <given-names>GF</given-names></name><name><surname>Smith</surname> <given-names>AN</given-names></name><name><surname>Miller</surname> <given-names>L-AD</given-names></name><name><surname>Radice</surname> <given-names>GL</given-names></name><name><surname>West-Mays</surname> <given-names>JA</given-names></name><name><surname>Lang</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Co-operative roles for E-cadherin and N-cadherin during lens vesicle separation and lens epithelial cell survival</article-title><source>Developmental Biology</source><volume>326</volume><fpage>403</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.10.011</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quilliam</surname> <given-names>LA</given-names></name><name><surname>Rebhun</surname> <given-names>JF</given-names></name><name><surname>Castro</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases</article-title><source>Progress in Nucleic Acid Research and Molecular Biology</source><volume>71</volume><fpage>391</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1016/S0079-6603(02)71047-7</pub-id><pub-id pub-id-type="pmid">12102558</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname> <given-names>PV</given-names></name><name><surname>Maddala</surname> <given-names>R</given-names></name><name><surname>John</surname> <given-names>F</given-names></name><name><surname>Zigler</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Expression of nonphagocytic NADPH oxidase system in the ocular lens</article-title><source>Molecular Vision</source><volume>10</volume><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">14978478</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridley</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Life at the leading edge</article-title><source>Cell</source><volume>145</volume><fpage>1012</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.06.010</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>AE</given-names></name><name><surname>Araki</surname> <given-names>T</given-names></name><name><surname>Swanson</surname> <given-names>KD</given-names></name><name><surname>Montgomery</surname> <given-names>KT</given-names></name><name><surname>Schiripo</surname> <given-names>TA</given-names></name><name><surname>Joshi</surname> <given-names>VA</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Yassin</surname> <given-names>Y</given-names></name><name><surname>Tamburino</surname> <given-names>AM</given-names></name><name><surname>Neel</surname> <given-names>BG</given-names></name><name><surname>Kucherlapati</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Germline gain-of-function mutations in SOS1 cause Noonan syndrome</article-title><source>Nature Genetics</source><volume>39</volume><fpage>70</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/ng1926</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>AW</given-names></name><name><surname>Kim</surname> <given-names>C</given-names></name><name><surname>Zhen</surname> <given-names>L</given-names></name><name><surname>Lowe</surname> <given-names>JB</given-names></name><name><surname>Kapur</surname> <given-names>R</given-names></name><name><surname>Petryniak</surname> <given-names>B</given-names></name><name><surname>Spaetti</surname> <given-names>A</given-names></name><name><surname>Pollock</surname> <given-names>JD</given-names></name><name><surname>Borneo</surname> <given-names>JB</given-names></name><name><surname>Bradford</surname> <given-names>GB</given-names></name><name><surname>Atkinson</surname> <given-names>SJ</given-names></name><name><surname>Dinauer</surname> <given-names>MC</given-names></name><name><surname>Williams</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense</article-title><source>Immunity</source><volume>10</volume><fpage>183</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80019-9</pub-id><pub-id pub-id-type="pmid">10072071</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>ML</given-names></name><name><surname>Ohtaka-Maruyama</surname> <given-names>C</given-names></name><name><surname>Chan</surname> <given-names>CC</given-names></name><name><surname>Jamieson</surname> <given-names>S</given-names></name><name><surname>Dickson</surname> <given-names>C</given-names></name><name><surname>Overbeek</surname> <given-names>PA</given-names></name><name><surname>Chepelinsky</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Disregulation of ocular morphogenesis by lens-specific expression of FGF-3/int-2 in transgenic mice</article-title><source>Developmental Biology</source><volume>198</volume><fpage>13</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1006/dbio.1998.8879</pub-id><pub-id pub-id-type="pmid">9640329</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>ML</given-names></name><name><surname>Overbeek</surname> <given-names>PA</given-names></name><name><surname>Verran</surname> <given-names>DJ</given-names></name><name><surname>Grizzle</surname> <given-names>WE</given-names></name><name><surname>Stockard</surname> <given-names>CR</given-names></name><name><surname>Friesel</surname> <given-names>R</given-names></name><name><surname>Maciag</surname> <given-names>T</given-names></name><name><surname>Thompson</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice</article-title><source>Development</source><volume>121</volume><fpage>505</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">7539358</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubbert</surname> <given-names>S</given-names></name><name><surname>Zenker</surname> <given-names>M</given-names></name><name><surname>Rowe</surname> <given-names>SL</given-names></name><name><surname>Böll</surname> <given-names>S</given-names></name><name><surname>Klein</surname> <given-names>C</given-names></name><name><surname>Bollag</surname> <given-names>G</given-names></name><name><surname>van der Burgt</surname> <given-names>I</given-names></name><name><surname>Musante</surname> <given-names>L</given-names></name><name><surname>Kalscheuer</surname> <given-names>V</given-names></name><name><surname>Wehner</surname> <given-names>L-E</given-names></name><name><surname>Nguyen</surname> <given-names>H</given-names></name><name><surname>West</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>KYJ</given-names></name><name><surname>Sistermans</surname> <given-names>E</given-names></name><name><surname>Rauch</surname> <given-names>A</given-names></name><name><surname>Niemeyer</surname> <given-names>CM</given-names></name><name><surname>Shannon</surname> <given-names>K</given-names></name><name><surname>Kratz</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Germline KRAS mutations cause Noonan syndrome</article-title><source>Nature Genetics</source><volume>38</volume><fpage>331</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/ng1748</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname> <given-names>K</given-names></name><name><surname>Kawauchi</surname> <given-names>T</given-names></name><name><surname>Kubo</surname> <given-names>K</given-names></name><name><surname>Honda</surname> <given-names>T</given-names></name><name><surname>Herz</surname> <given-names>J</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Kinashi</surname> <given-names>T</given-names></name><name><surname>Nakajima</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Reelin controls neuronal positioning by promoting cell-matrix adhesion via inside-out activation of integrin α5β1</article-title><source>Neuron</source><volume>76</volume><fpage>353</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.07.020</pub-id><pub-id pub-id-type="pmid">23083738</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname> <given-names>JH</given-names></name><name><surname>Suenaga</surname> <given-names>A</given-names></name><name><surname>Hatakeyama</surname> <given-names>M</given-names></name><name><surname>Taiji</surname> <given-names>M</given-names></name><name><surname>Imamoto</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>3076</fpage><lpage>3087</lpage><pub-id pub-id-type="doi">10.1128/MCB.01686-08</pub-id><pub-id pub-id-type="pmid">19307307</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settleman</surname> <given-names>J</given-names></name><name><surname>Baum</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cell shape and tissue morphogenesis</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>19</volume><fpage>213</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2008.02.002</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>L</given-names></name><name><surname>Sasaki</surname> <given-names>Y</given-names></name><name><surname>Calado</surname> <given-names>DP</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Paik</surname> <given-names>JH</given-names></name><name><surname>DePinho</surname> <given-names>RA</given-names></name><name><surname>Kutok</surname> <given-names>JL</given-names></name><name><surname>Kearney</surname> <given-names>JF</given-names></name><name><surname>Otipoby</surname> <given-names>KL</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>PI3 kinase signals BCR-dependent mature B cell survival</article-title><source>Cell</source><volume>139</volume><fpage>573</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.08.041</pub-id><pub-id pub-id-type="pmid">19879843</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>N</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>He</surname> <given-names>Q</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Luo</surname> <given-names>F</given-names></name><name><surname>Yi</surname> <given-names>L</given-names></name><name><surname>Du</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Deng</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Generation of <italic>Fgfr3</italic> conditional knockout mice</article-title><source>International Journal of Biological Sciences</source><volume>6</volume><fpage>327</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.7150/ijbs.6.327</pub-id><pub-id pub-id-type="pmid">20582225</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sue Menko</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Lens epithelial cell differentiation</article-title><source>Experimental Eye Research</source><volume>75</volume><fpage>485</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1006/exer.2002.2057</pub-id><pub-id pub-id-type="pmid">12457861</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>S</given-names></name><name><surname>Morishita</surname> <given-names>T</given-names></name><name><surname>Hashimoto</surname> <given-names>Y</given-names></name><name><surname>Hattori</surname> <given-names>S</given-names></name><name><surname>Nakamura</surname> <given-names>S</given-names></name><name><surname>Shibuya</surname> <given-names>M</given-names></name><name><surname>Matuoka</surname> <given-names>K</given-names></name><name><surname>Takenawa</surname> <given-names>T</given-names></name><name><surname>Kurata</surname> <given-names>T</given-names></name><name><surname>Nagashima</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins</article-title><source>PNAS</source><volume>91</volume><fpage>3443</fpage><lpage>3447</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.8.3443</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tartaglia</surname> <given-names>M</given-names></name><name><surname>Mehler</surname> <given-names>EL</given-names></name><name><surname>Goldberg</surname> <given-names>R</given-names></name><name><surname>Zampino</surname> <given-names>G</given-names></name><name><surname>Brunner</surname> <given-names>HG</given-names></name><name><surname>Kremer</surname> <given-names>H</given-names></name><name><surname>van der Burgt</surname> <given-names>I</given-names></name><name><surname>Crosby</surname> <given-names>AH</given-names></name><name><surname>Ion</surname> <given-names>A</given-names></name><name><surname>Jeffery</surname> <given-names>S</given-names></name><name><surname>Kalidas</surname> <given-names>K</given-names></name><name><surname>Patton</surname> <given-names>MA</given-names></name><name><surname>Kucherlapati</surname> <given-names>RS</given-names></name><name><surname>Gelb</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</article-title><source>Nature Genetics</source><volume>29</volume><fpage>465</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/ng772</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tartaglia</surname> <given-names>M</given-names></name><name><surname>Pennacchio</surname> <given-names>LA</given-names></name><name><surname>Zhao</surname> <given-names>C</given-names></name><name><surname>Yadav</surname> <given-names>KK</given-names></name><name><surname>Fodale</surname> <given-names>V</given-names></name><name><surname>Sarkozy</surname> <given-names>A</given-names></name><name><surname>Pandit</surname> <given-names>B</given-names></name><name><surname>Oishi</surname> <given-names>K</given-names></name><name><surname>Martinelli</surname> <given-names>S</given-names></name><name><surname>Schackwitz</surname> <given-names>W</given-names></name><name><surname>Ustaszewska</surname> <given-names>A</given-names></name><name><surname>Martin</surname> <given-names>J</given-names></name><name><surname>Bristow</surname> <given-names>J</given-names></name><name><surname>Carta</surname> <given-names>C</given-names></name><name><surname>Lepri</surname> <given-names>F</given-names></name><name><surname>Neri</surname> <given-names>C</given-names></name><name><surname>Vasta</surname> <given-names>I</given-names></name><name><surname>Gibson</surname> <given-names>K</given-names></name><name><surname>Curry</surname> <given-names>CJ</given-names></name><name><surname>Siguero</surname> <given-names>JPL</given-names></name><name><surname>Digilio</surname> <given-names>MC</given-names></name><name><surname>Zampino</surname> <given-names>G</given-names></name><name><surname>Dallapiccola</surname> <given-names>B</given-names></name><name><surname>Bar-Sagi</surname> <given-names>D</given-names></name><name><surname>Gelb</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome</article-title><source>Nature Genetics</source><volume>39</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/ng1939</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuveson</surname> <given-names>DA</given-names></name><name><surname>Shaw</surname> <given-names>AT</given-names></name><name><surname>Willis</surname> <given-names>NA</given-names></name><name><surname>Silver</surname> <given-names>DP</given-names></name><name><surname>Jackson</surname> <given-names>EL</given-names></name><name><surname>Chang</surname> <given-names>S</given-names></name><name><surname>Mercer</surname> <given-names>KL</given-names></name><name><surname>Grochow</surname> <given-names>R</given-names></name><name><surname>Hock</surname> <given-names>H</given-names></name><name><surname>Crowley</surname> <given-names>D</given-names></name><name><surname>Hingorani</surname> <given-names>SR</given-names></name><name><surname>Zaks</surname> <given-names>T</given-names></name><name><surname>King</surname> <given-names>C</given-names></name><name><surname>Jacobetz</surname> <given-names>MA</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Bronson</surname> <given-names>RT</given-names></name><name><surname>Orkin</surname> <given-names>SH</given-names></name><name><surname>DePinho</surname> <given-names>RA</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects</article-title><source>Cancer Cell</source><volume>5</volume><fpage>375</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/S1535-6108(04)00085-6</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhya</surname> <given-names>D</given-names></name><name><surname>Ogata</surname> <given-names>M</given-names></name><name><surname>Reneker</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MAPK1 is required for establishing the pattern of cell proliferation and for cell survival during lens development</article-title><source>Development</source><volume>140</volume><fpage>1573</fpage><lpage>1582</lpage><pub-id pub-id-type="doi">10.1242/dev.081042</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname> <given-names>GF</given-names></name><name><surname>Menko</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Actin filament organization regulates the induction of lens cell differentiation and survival</article-title><source>Developmental Biology</source><volume>295</volume><fpage>714</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.03.056</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Ohyama</surname> <given-names>K</given-names></name><name><surname>Deng</surname> <given-names>CX</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung</article-title><source>Development</source><volume>125</volume><fpage>3615</fpage><lpage>3623</lpage><pub-id pub-id-type="pmid">9716527</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Ingram</surname> <given-names>DA</given-names></name><name><surname>Quilliam</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions</article-title><source>Molecular and Cellular Biology</source><volume>28</volume><fpage>5803</fpage><lpage>5810</lpage><pub-id pub-id-type="doi">10.1128/MCB.00393-08</pub-id><pub-id pub-id-type="pmid">18625726</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Sosic</surname> <given-names>D</given-names></name><name><surname>Shao</surname> <given-names>J</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name><name><surname>Towler</surname> <given-names>DA</given-names></name><name><surname>Ornitz</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth</article-title><source>Development</source><volume>130</volume><fpage>3063</fpage><lpage>3074</lpage><pub-id pub-id-type="doi">10.1242/dev.00491</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>EE</given-names></name><name><surname>Chapeau</surname> <given-names>E</given-names></name><name><surname>Hagihara</surname> <given-names>K</given-names></name><name><surname>Feng</surname> <given-names>G-S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism</article-title><source>PNAS</source><volume>101</volume><fpage>16064</fpage><lpage>16069</lpage><pub-id pub-id-type="doi">10.1073/pnas.0405041101</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>T</given-names></name><name><surname>Madakashira</surname> <given-names>BP</given-names></name><name><surname>Thiels</surname> <given-names>CA</given-names></name><name><surname>Bechtle</surname> <given-names>CA</given-names></name><name><surname>Garcia</surname> <given-names>CM</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Yu</surname> <given-names>K</given-names></name><name><surname>Ornitz</surname> <given-names>DM</given-names></name><name><surname>Beebe</surname> <given-names>DC</given-names></name><name><surname>Robinson</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Fibroblast growth factor receptor signaling is essential for lens fiber cell differentiation</article-title><source>Developmental Biology</source><volume>318</volume><fpage>276</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.03.028</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.32586.018</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Horsley</surname><given-names>Valerie</given-names></name><role>Reviewing Editor</role><aff id="aff8"><institution>Yale University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Crk proteins transduce FGF signaling to promote lens fiber cell elongation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Fiona Watt as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Mark Lewandoski (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The reviewers thought that your manuscript utilizes sophisticated genetics and biochemistry to reveal the components and interactions downstream of FGF signaling during the morphogenesis of the mouse lens. They felt that your work has important implications for how molecular signaling controls cell shape. Furthermore, the experiments were described as well executed and the findings as very interesting. The reviewers describe concerns that should be addressed before publication as detailed below.</p><p>Essential revisions:</p><p>1) There were concerns that &quot;Le-Cre only mice were used as controls.&quot; It is important to have Le-Cre in the controls, because Le-Cre itself can have an effect on eye development (PLoS One. 2014 Oct 1;9(10):e109193). But it is also important that littermates are used as controls to rule out differences due to genetic background affecting phenotypes (and the Le-Cre alone effect is background dependent!). This is a big problem as the authors would have to repeat a lot of experiments. Short of doing that work, perhaps the authors can argue that there was little or no variation in phenotypes? Thus the authors should mention how many samples were examined (hopefully at least three) and mention somewhere what variation was observed. It might also help to include a table listing all the genetic crosses, with parental genotypes and the important experimental progeny.</p><p>2) Some other histological phenotypes in the Crk/L-cKO mutants are not adequately described. For example, the lens epithelial layer appears missing (<xref ref-type="fig" rid="fig2">Figure 2H, J, L, N, P</xref>). Also, there is an abnormal optic cub protrusion posterior to the lens vesicle in Crk/L-cKO mutants. The authors need to describe these phenotypes in more detail, and explain how these phenotypes are affected in other mutant backgrounds. If the lens epithelium is indeed disrupted, could this phenotype affect the maintenance of the polarity of primary fibers and the generation of secondary lens fibers? Also, given the lens-specific deletion of Crk/L, why does the mutation cause the abnormality in the optic cup?</p><p>3) The authors emphasize the co-expression of the pCrk/L and pERK in the transitional zone, where proliferation and differentiation of secondary lens fibers occurs, at E14.5. However, the Crk/L-cKO lens phenotype appears between E10.5 and E12.5. The authors should compare the pCrk/L and pER expression at these earlier stages to strengthen their argument.</p><p>4). In <xref ref-type="fig" rid="fig3">Figure 3C</xref>, it appears that the loss of Crk/L mainly affects the substantiation of pERK after FGF2 treatment. Quantification of the western blotting should be very informative here. It would be interesting that Crk/L modify the quantity of FGF-ERK signaling by prolonging ERK activation.</p><p>5) &quot;Despite the severe morphological defects, Prox1, Pax6 and multiple forms of crystallin (α,β,γ) were expressed without delay (<xref ref-type="fig" rid="fig2">Figure 2A-N</xref>).&quot; The provided data do not demonstrate the normal onset of Pax6. The authors need to modify the statement or provide additional data to support the statement. Also, authors should indicate that the Pax6+ lens epithelium is greatly reduced and shifted to the ventral position in the mutant.</p><p>6) <xref ref-type="fig" rid="fig6">Figure 6H</xref>, the authors should provide quantitative data to demonstrate the partial rescue of the Crk/L-cKO phenotype by Rac1-ca.</p><p>7) <xref ref-type="fig" rid="fig6">Figure 6U</xref> and <xref ref-type="fig" rid="fig7">Figure 7B</xref>, are post hoc tests used to confirm where the difference occurs between groups after a statistically significant one-way ANOVA test?</p><p>8) In the Abstract, the authors claim that Crk proteins are recruited to the Frs2/Sjp2/Grb2 signaling complex upon FGF signaling. The author should tone down that assertion because there is no direct evidence that Grb2 is a part of the complex.</p><p>9) In both Introduction and Discussion, many statements referring to published findings lack references. The authors need to revise these sections and add proper citations.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.32586.019</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) There were concerns that &quot;Le-Cre only mice were used as controls.&quot; It is important to have Le-Cre in the controls, because Le-Cre itself can have an effect on eye development (PLoS One. 2014 Oct 1;9(10):e109193). But it is also important that littermates are used as controls to rule out differences due to genetic background affecting phenotypes (and the Le-Cre alone effect is background dependent!). This is a big problem as the authors would have to repeat a lot of experiments. Short of doing that work, perhaps the authors can argue that there was little or no variation in phenotypes? Thus the authors should mention how many samples were examined (hopefully at least three) and mention somewhere what variation was observed. It might also help to include a table listing all the genetic crosses, with parental genotypes and the important experimental progeny.</p></disp-quote><p>We are aware that Le-Cre mice appear normal in the original FVB/N background but present ocular abnormalities in the CBA/Ca background as shown in the citation above, thus we always use Le-Cre mice as controls instead of wild type (+/+) animals. As described in the revised Materials and methods section, we believe such controls are justified because we did not observe any phenotypic differences between Le-Cre and Le-Cre;Crkflox/+;CrkLflox/+ mice in our mixed genetic background. Moreover, lens development was consistent and reproducible among these controls as shown by the modest variations in our quantifications (see <xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig4">4B</xref>, for example). The revised Materials and methods section now includes a table of all the genetic crosses and confirms that at least three animals are examined for each genotype.</p><disp-quote content-type="editor-comment"><p>2) Some other histological phenotypes in the Crk/L-cKO mutants are not adequately described. For example, the lens epithelial layer appears missing (<xref ref-type="fig" rid="fig2">Figure 2H, J, L, N, P</xref>). Also, there is an abnormal optic cub protrusion posterior to the lens vesicle in Crk/L-cKO mutants. The authors need to describe these phenotypes in more detail, and explain how these phenotypes are affected in other mutant backgrounds. If the lens epithelium is indeed disrupted, could this phenotype affect the maintenance of the polarity of primary fibers and the generation of secondary lens fibers? Also, given the lens-specific deletion of Crk/L, why does the mutation cause the abnormality in the optic cup?</p></disp-quote><p>We highlight <xref ref-type="fig" rid="fig2">Figure 2</xref> to show that the lens epithelial layer is diminished but not missing in Crk/L-cKO mutants (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, arrowheads). Using apical marker Zo-1 and basal marker β1 integrin, we now show that the polarity of the lens fiber cells is also maintained (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). We also cited earlier work that show the disruption of lens development can lead to disorganization of the retina, which we believe explains the protrusion/abnormality of the optic cup in Crk/L-cKO mutants.</p><disp-quote content-type="editor-comment"><p>3) The authors emphasize the co-expression of the pCrk/L and pERK in the transitional zone, where proliferation and differentiation of secondary lens fibers occurs, at E14.5. However, the Crk/L-cKO lens phenotype appears between E10.5 and E12.5. The authors should compare the pCrk/L and pER expression at these earlier stages to strengthen their argument.</p></disp-quote><p>The pCrk/L and pERK expressions at E12.5 are now added to <xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="fig" rid="fig3">Figure 3D</xref>, respectively.</p><disp-quote content-type="editor-comment"><p>4). In <xref ref-type="fig" rid="fig3">Figure 3C</xref>, it appears that the loss of Crk/L mainly affects the substantiation of pERK after FGF2 treatment. Quantification of the western blotting should be very informative here. It would be interesting that Crk/L modify the quantity of FGF-ERK signaling by prolonging ERK activation.</p></disp-quote><p>Good advice. We have quantified the western blots in <xref ref-type="fig" rid="fig3">Figure 3C</xref>, which indeed showed that depletion of Crk/L reduced both the intensity and duration of FGF-ERK signaling. This interesting observation is now described in the text.</p><disp-quote content-type="editor-comment"><p>5) &quot;Despite the severe morphological defects, Prox1, Pax6 and multiple forms of crystallin (α,β,γ) were expressed without delay (<xref ref-type="fig" rid="fig2">Figure 2A-N</xref>).&quot; The provided data do not demonstrate the normal onset of Pax6. The authors need to modify the statement or provide additional data to support the statement. Also, authors should indicate that the Pax6+ lens epithelium is greatly reduced and shifted to the ventral position in the mutant.</p></disp-quote><p>We agree. This sentence is revised to only state that these lens markers are still expressed in the Crk/L-cKO mutant lens and it is noted that the lens epithelium is diminished and rotated ventrally.</p><disp-quote content-type="editor-comment"><p>6) <xref ref-type="fig" rid="fig6">Figure 6H</xref>, the authors should provide quantitative data to demonstrate the partial rescue of the Crk/L-cKO phenotype by Rac1-ca.</p></disp-quote><p>The quantification is presented in <xref ref-type="fig" rid="fig6">Figure 6U</xref> (the last two columns).</p><disp-quote content-type="editor-comment"><p>7) <xref ref-type="fig" rid="fig6">Figure 6U</xref> and <xref ref-type="fig" rid="fig7">Figure 7B</xref>, are post hoc tests used to confirm where the difference occurs between groups after a statistically significant one-way ANOVA test?</p></disp-quote><p>As now described in the figure legends, Tukey's multiple comparisons test was used after one-way ANOVA test.</p><disp-quote content-type="editor-comment"><p>8) In the Abstract, the authors claim that Crk proteins are recruited to the Frs2/Sjp2/Grb2 signaling complex upon FGF signaling. The author should tone down that assertion because there is no direct evidence that Grb2 is a part of the complex.</p></disp-quote><p>Agree. The modified sentence now only note that Crk proteins interact with Grb2 upon FGF signaling.</p><disp-quote content-type="editor-comment"><p>9) In both Introduction and Discussion, many statements referring to published findings lack references. The authors need to revise these sections and add proper citations.</p></disp-quote><p>We apologize for the oversight and added additional references as we have originally intended to.</p></body></sub-article></article>